WHO Global Coordination Mechanism COPENHAGEN, DENMARK on the Prevention and Control 9–11 APRIL of Noncommunicable Diseases
Global Dialogue on Partnerships for Sustainable Financing of NCD Prevention and Control
MEETING REPORT WHO/NMH/NMA/GCM/19.01 © World Health Organization 2019
Some rights reserved. This work is available under the Creative Commons Attribution- NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons. org/licenses/by-nc-sa/3.0/igo).
Under the terms of this licence, you may copy, redistribute and adapt the work for non- commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.
Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.
Suggested citation. Global Dialogue on Partnerships for Sustainable Financing of NCD Prevention Control. Meeting report, Copenhagen, Denmark, 9–11 April 2018. Geneva: World Health Organization; 2019 (WHO/NMH/NMA/GCM/19.01). Licence: CC BY-NC-SA 3.0 IGO.
Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris.
Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/ bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.
Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.
General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use.
The contents of this publication do not necessarily reflect the views of any Global Dialogue partner organization, OECD member countries, or the European Commission. ACKNOWLEDGEMENTS
This report was made possible thanks to the support and contribution of many individuals from the World Health Organization’s Noncommunicable Diseases and Mental Health Cluster and the colleagues from all WHO regional offices, Government of Denmark and partner organizations. Special thanks are due to the co-chairs and members of the Global Dialogue Steering, Programme and Advisory Committees for their intellectual support and strategic guidance: Bente Mikkelsen, Birgitte Mossin Bronden, Téa Collins, Katie Dain, Bent Lautrup-Nielsen, Nick Banatvala, Douglas Bettcher, Francesco Branca, Vanessa Candeias, Annie Chu, Guy Fones, Paul Garwood, Sophie Genay-Diliautas, Marta Guglielmetti, Asmus Hammerich, Anselm Hennis, Gitte Hundahl, Priya Kanayson, Etienne Krug, Alexey Kulikov, Grega Kumer, Mary-Anne Land, Lina Mahy, Daniel Míc, Line Neerup Handlos, James Pfitzer, Marge Reinap, Dag Rekve, Shekhar Saxena, Hai-Rai Shin, Steven Shongwe, Slim Slama, Thaksaphon Thamarangsi, Menno Van Hilten, Tatiana Vorovchenko. Overall guidance was provided by Svetlana Akselrod.
Téa Collins acted as principle drafter of this report and oversaw the development and design of the document with technical support by Ayodele Akinnawo.
Warm thanks are extended to the WHO GCM/NCD participants, including dialogue and working group co-chairs, members, and special advisers for their participation and valuable expertise ensuring a successful Global Dialogue meeting.
Significant technical and financial contributions made by the World Diabetes Foundation, World Economic Forum, NCD Alliance, International Federation of Pharmaceutical Manufacturers & Associations and Organisation for Economic Co-operation and Development are gratefully acknowledged.
Editorial support was provided by John Dawson.
Art Direction and Design: Human After All. CONTENTS
Foreword 6
1. Global Dialogue: overview 8
2. Daily programme of the Global Dialogue 10
Day 1 14
Opening ceremony 14
Plenary session 1. Setting the stage: the role of partnerships 19 and innovative financing to accelerate national NCD responses
Plenary session 2. Development cooperation for NCDs: aligning and 21 leveraging domestic and external resources to achieve SDG target 3.4
Day 2 26
Plenary session 3. Exploring synergies between financing national NCD 26 responses and broader health systems strengthening efforts for universal health coverage: launch of the report of the Lancet Taskforce on NCDs and economics
Plenary session 4. Summary of key outcomes 29
Day 3 29
Plenary session 5. Synthesis: summary, conclusion 29 and recommendations
Plenary session 6. Multistakeholder and multisectoral action: 34 a means to unlock financing for NCDs
Programme of meeting 37
3. Global Dialogue outcomes 48
3.1 High-level summary 50
3.2 Copenhagen Global Dialogue recommendations for accelerating 52 national NCD responses
The role of partnerships and innovative financing to accelerate national 52 NCD responses
Development cooperation for NCDs: aligning and leveraging external 52 and domestic resources to achieve SDG target 3.4
Exploring synergies between financing national NCD responses 54 and broader health systems strengthening efforts for universal health coverage
4 | WHO – Copenhagen Report CONTENTS
3.3 Key messages from multistakeholder and multisectoral dialogue 55 and partnership forums
Parallel session 2.1. Mobilizing resources for a joint United Nations system 55 response to NCDs: the role of development cooperation
Parallel session 2.2. Mobilizing domestic resources for NCDs: learning from 55 country experiences
Parallel session 2.3. How to harness the power of the private sector 56 to implement national NCD responses
Parallel session 2.4. Measuring resource flows into NCDs: current trends 56 and projections
Parallel session 3.1. Political economy of universal health coverage for NCDs: 56 what are the necessary economic, social and political preconditions to make universal health coverage for NCDs a realistic goal for all?
Parallel session 3.2. Investing in innovative service delivery models towards 56 integrated person-centred care for NCDs
Parallel session 3.3. Building the investment case for NCD prevention 57 and control
Parallel session 3.4. Cost-effective and feasible solutions: WHO “best buys” 57
Partnership forum 1. Scaling up digital health for NCDs: 57 leaving no one behind
Partnership forum 2. NCDs and mental health in emergencies: 57 beyond current financing
Partnership forum 3. A vital investment: scaling up health workforce for NCDs 58
Partnership forum 4. Accelerating access to medicines and new technologies 58 in low- and middle-income countries: viable models for innovative partnerships
Partnership forum 5. Advocacy for resource mobilization for NCDs: 58 the role of civil society for holding stakeholders accountable
Partnership forum 6. Creating a shared value: aligning commercial 58 and public health interests to tackle NCDs
4. Annexes 60
Annex 1. Plenary speeches and presentations 62
Annex 2. Participants and listings 65
Annex 3. Image gallery 98
5
Foreword
It is well known that noncommunicable diseases (NCDs), such to overcome the NCD epidemic. WHO recognizes the need for as cardiovascular diseases, cancers, chronic obstructive lung urgent action. This is why, in the lead-up to the third High-level disease and diabetes, are affecting millions of people worldwide, Meeting on the Prevention and Control of NCDs, the prematurely taking lives at all stages of the life course from very Government of Denmark and the WHO Global Coordination young to old age. It is also common knowledge that over three Mechanism on the Prevention and Control of NCDs (GCM/ quarters of these deaths occur in low- and middle-income NCD) co-organized a Global Dialogue on Partnerships for countries, many of which continue to struggle with devastating Sustainable Financing of NCD Prevention and Control from consequences of HIV/AIDS, malaria, tuberculosis (TB) and 9 to 11 April, 2018, in Copenhagen, Denmark. The Global other infectious diseases, as well as high maternal and child Dialogue brought together high-level participants from mortality and morbidity and lack of access to health services. Member States, representatives of royal families, United NCDs also impose large and often avoidable costs on already Nations system organizations, academia, civil society, stretched government budgets and economies at large, professional associations and the private sector to discuss the and exacerbate poverty. challenges and come up with innovative solutions to address Until recently, the development agenda for NCDs had the critical gap in resource mobilization for accelerating not stressed enough the need for more resource mobilization national NCD responses. It was truly the expertise and to address NCD prevention and control. As a result, the urgency commitment of all participants that made the Global Dialogue of the problem has not translated into effective country-level a success. I would like to thank all who contributed their action. The large inequality in the burden of NCDs and domestic valuable knowledge to this important event. The remarkable resources to address them continues to remain, highlighting leadership of the Government of Denmark and the sponsoring the North–South divide. In addition, information and knowledge partners, such as the Organisation for Economic Co-operation gaps at global, regional and country levels impede the effective and Development (OECD), World Diabetes Foundation, mobilization of predictable and sustained financing for NCDs International Federation of Pharmaceutical Manufacturers to ensure the implementation of best practices, efficient use and Associations (IFPMA), World Economic Forum, of resources, and advancement of universal health coverage, and NCD Alliance, is gratefully acknowledged. to include NCDs. The Global Dialogue assessed the progress made since Now that NCDs are firmly embedded in the 2030 Agenda the first High-level Meeting on NCDs in 2011 and stressed for Sustainable Development with a commitment at the highest the need for international cooperation and partnerships level to reduce, by one third, premature mortality from NCDs to increase financing for NCDs. I hope you enjoy reading through prevention and treatment and promote mental health this report, which captures the major highlights of the Global and well-being (SDG target 3.4), a coordinated response from Dialogue and offers specific actionable recommendations a multitude of actors, including governments, multilateral on financing NCD prevention and control. The numerous organizations, civil society and the private sector, will be speeches and presentations from key speakers also shed paramount. Only through a concerted multisectoral light on how we can move forward from global commitments and multistakeholder approach can we achieve the NCD- to local actions. We are very pleased with the outcomes related and other ambitious health targets of the 2030 of the Global Dialogue and hope you find this report Agenda, as public resources alone will not be sufficient an important resource. The time is now to deliver.
Dr Svetlana Akselrod Assistant Director-General Noncommunicable Diseases and Mental Health World Health Organization
7
Global Dialogue: overview
01 OVERVIEW
More than 300 participants from over 56 countries, including themes into more focused topics to be explored further. governments, United Nations agencies and non-State actors, The parallel sessions also included multistakeholder and came together on 9–11 April 2018 in Copenhagen, Denmark, multisectoral partnership forums. The partnership forums were to share ideas and best practices, to create and strengthen moderated sessions with the goal of addressing specific areas partnerships, and to discuss and debate how to find of action on NCDs, such as digital health, mental health sustainable solutions to reach the noncommunicable disease and emergencies, innovative service delivery models, and (NCD) target 3.4 of the 2030 Agenda for Sustainable strengthening of the human workforce, where the power Development: “By 2030, reduce by one third premature of public–private partnerships can be harnessed for the mortality from non-communicable diseases through greater public good. prevention and treatment and promote mental health The Global Dialogue provided an effective platform and well-being”. The occasion was the World Health for major announcements and launches of various Organization (WHO) Global Dialogue on Partnerships commitments and reports, including the launch of the WHO for Sustainable Financing of NCD Prevention and Control, Global Coordination Mechanism on the Prevention and Control of NCDs (GCM/NCD) Working Group report on the alignment of international cooperation with national NCD strategies By 2030, reduce by one third and plans, and the launch of the Lancet series on NCDs premature mortality from and economics. The Government of Denmark announced its commitment non-communicable diseases to support the Defeat-NCD Partnership and set up an SDG through prevention and fund to secure the implementation of the 2030 Agenda for Sustainable Development, focusing on the challenges that treatment and promote mental low- and middle-income countries face. The Youth Innovation Lab convened on the margins health and well-being. of the Global Dialogue to allow young talents to co-create innovative ideas that could contribute to increased co-organized by the Government of Denmark and WHO. mobilization of resources for improved NCD financing. Over the course of three days, representatives of government The project was a collaborative effort of the World Diabetes ministries, academia, nongovernmental organizations (NGOs), Foundation, NCD Child, NCDFREE, the International Federation philanthropic foundations, professional associations and the of Medical Students’ Associations and the Young Professionals private sector convened to discuss how collective efforts, Chronic Disease Network. The Youth Innovation Lab brought innovative approaches and multistakeholder partnerships can 20 carefully selected young leaders from all over the world take forward governance, accountability, resource mobilization to participate in the event, take part in selected parallel and intersectoral action to accelerate the implementation of sessions, and propose concrete creative solutions. The most high-level political commitments for the achievement of the innovative talent teams presented their ideas in the summary Sustainable Development Goals (SDGs) at the local level. plenary and eventually progressed to the prestigious UNLEASH The conference sessions encompassed formal plenaries, Innovation Lab in Singapore to further develop their ideas for as well as parallel sessions, which broke down the plenary potentially funded projects.
10 | WHO – Copenhagen Report Conference documents distributed to delegates included The two event-specific a conference programme, a brochure (including a practical information section), and profiles of speakers and moderators. hashtags, #NCDdialogue and A mobile app providing information about the event, as well as #NCDyouthlab, collectively some background documents, was also available to download. All conference details and news items are now available to view reached nearly 6 million people, at who.int/conferences/global-ncd-conference/financing/en. The two event-specific hashtags, #NCDdialogue and while the reach of WHO totalled #NCDyouthlab, collectively reached nearly 6 million people, 13 117 772 during the week of the while the reach of WHO totalled 13 117 772 during the week of the Global Dialogue. Global Dialogue.
515 414 12,779,674 1 3,1 17,7 7 2 POSTS USERS REACH IMPRESSIONS
Timeline
250
200
150
100
50
0 MAR MAR MAR MAR MAR MAR MAR MAR APR APR APR APR APR 11 14 14 17 23 14 26 29 29 01 04 07 10
11
Daily programme of the Global Dialogue 02 DAY 1
The first day of the Global Dialogue set the stage for the Opening ceremony coming days by reviewing the commitments made since the first High-level Meeting of the United Nations General Assembly on the Prevention and Control of Non-communicable High-level representatives of the Government of Denmark, Diseases in 2011, and defining the current NCD financing WHO, the Royal Family of Denmark, and the youth landscape. The high-level speakers repeatedly stressed the constituency opened the Global Dialogue with inspiring importance of multisectoral and multistakeholder partnerships speeches underscoring the power of partnerships and for the implementation of the 2030 Agenda for Sustainable international cooperation to trigger innovation, mobilize Development and accelerating national NCD responses. untapped resources and deliver results for comprehensive The 2030 Agenda is built on the premise that collaborative NCD prevention and control. The speakers also stressed that “business as usual” was no longer an option. As countries move forward The four major groups of NCDs – cardiovascular diseases, cancer, chronic respiratory diseases and diabetes – and their with the implementation of the shared risk factors (tobacco use, unhealthy diets, lack of physical activity and harmful use of alcohol) are contributing 2030 Agenda for Sustainable to over 72% of deaths globally. More importantly, NCDs Development, greater intersectoral take lives of people when they are most productive: according to WHO, there were over 15 million premature coherence and integration will deaths (between the ages of 30 and 69) globally in 2016, and more than 80% of these deaths took place in low- be needed to raise awareness, and middle-income countries.1 mobilize resources and make The speakers highlighted the significant progress made since the first United Nations High-level Meeting on NCDs NCD prevention and care available in 2011 in terms of increasing political support for the global NCD agenda. However, it was also stressed that the and affordable. translation of global commitments into effective country-level action had been relatively slow and uneven. partnerships are necessary to ensure that “no one is left As countries move forward with the implementation behind”. While the 2030 Agenda is equally applicable of the 2030 Agenda for Sustainable Development, scaling up to developing and developed countries, each country faces their efforts towards universal health coverage to meet SDG a unique set of challenges depending on its individual target 3.4, greater intersectoral coherence, integration and characteristics. Mainstreaming the SDGs into national health coordination of efforts and closer cooperation of the relevant system strategies and NCD plans will therefore require public and private sectors will be needed to raise awareness, integrated thinking, with all stakeholders from both the mobilize resources and make NCD prevention and care public and private sectors coming together in collaborative available and affordable. partnerships to pool resources, expertise and knowledge and support the achievement of the SDGs and, particularly, the NCD target set out in SDG target 3.4. The focus of the sessions on day 1 was on the topic of resource mobilization for accelerating national NCD action through aligning and leveraging domestic and international finances, including innovative financing mechanisms, development cooperation, and public–private partnerships.
¹ WHO Global Observatory data. NCD mortality and morbidity, 2018 (www.who.int/gho/ncd/mortality_morbidity/en).
14 | WHO – Copenhagen Report 15 DAY 1
Today’s dialogue meeting is a strong example of the power of partnerships’ potential to create shared value, a collective impact, and unity working towards a common goal. In short, working together to make it happen.
H.R.H. Crown Princess Mary of Denmark
We need new partnerships that can generate new money. Luckily, we do not need to only appeal to the philanthropic hearts of investors. Doing good can also be doing good business.
Ulla Tørnæs, Minister for Development Cooperation, Denmark
16 | WHO – Copenhagen Report DAY 1
WHO is working hard to provide the platforms and tools to make sure NCDs stay high on political, health and development agendas. We also advocate tirelessly for multisectoral and multistakeholder engagement and partnerships that demonstrate a clear value for health. Urgent action is needed now if the world is to reach the SDG target on NCDs.
Svetlana Akselrod, Assistant Director-General, WHO
Unless actions to address NCDs are prioritized, success in reaching many of the 2030 SDGs will be threatened. Investments in NCD prevention and control will provide high economic returns and clear win–win situations across sectors and stakeholders.
Bente Mikkelsen, Director a.i., Division of Noncommunicable Diseases and Promoting Health through the Life-course, WHO
17 DAY 1
Engaging young people in shaping and promoting the NCD agenda means ensuring that the efforts that are invested today to promote sustainable financing for NCDs and for universal health coverage won’t be lost tomorrow.
Dina Tadros, Youth Representative
18 | WHO – Copenhagen Report DAY 1
Plenary session 1 Setting the stage: the role of partnerships and innovative financing to accelerate national NCD responses
The first plenary session further stressed the urgent need for political action and for increased mobilization of resources if the commitments to decrease premature mortality from NCDs are to be translated into country-level action. Bold changes in the way countries finance the development and implementation of national NCD responses are needed; a more holistic, coherent and integrated multisectoral approach is necessary.
There is a complete mismatch between the NCD burden and the level of investments … The question is not if we should respond to NCDs; but rather how fast we can increase the investments.
Rifat Atun, Professor of Global Health Systems, Harvard University
19 DAY 1
Sustainable financing for NCDs means three things: (i) implementing health taxes and regulatory measures; (ii) funding health promotion activities; and (iii) implementing strategic purchasing.
Agnes Soucat, Director for Health Systems, Governance and Financing, WHO
It is essential to tap into the private sector’s expertise to help reach all patients at risk or suffering from NCDs. Discovering and developing new medicines and vaccines is our industry’s bread and butter, but we actually do much more than that: we foster innovation across the continuum of medical education, prevention, treatment and care. By participating in partnerships, we contribute to creating innovative finance models and build an evidence base that will be crucial to meet the NCD targets.
Thomas Cueni, Director-General, IFPMA
20 | WHO – Copenhagen Report DAY 1
Plenary session 2 Development cooperation for NCDs: aligning and leveraging domestic and external resources to achieve SDG target 3.4
The second plenary session brought together representatives of the Global Fund to Fight AIDS, Tuberculosis and Malaria, WHO, the Swiss Agency for Development and Cooperation, the Ministry of Finance of Uruguay, the private sector and NGOs to discuss the trends in NCD financing and the evolving role of development assistance. It was emphasized that external resources should be viewed as complementary to domestic resource mobilization efforts for NCD prevention and control. It was also mentioned that development assistance for NCDs has the potential to energize and offer significant co-benefits to other areas of global health, including maternal and child health, communicable diseases, health systems strengthening, and the social and environmental determinants of health. The speakers highlighted that international cooperation is more than just financing aid. It also includes technical collaboration, knowledge exchange, technology transfer and capacity- building activities through North–South, South–South and triangular cooperation. Special emphasis was placed on the power of the private sector to mobilize financial resources and technical expertise to implement national NCD responses. The parallel sessions that followed explored these themes in greater detail. The plenary session also provided an opportunity to launch the WHO GCM/NCD Working Group report on the alignment of international cooperation with national NCD plans.
21 DAY 1
Universal health coverage needs both a public and private sector engagement. We´re in the era when we have pluralistic multiprovider systems which are inclusive of both the public and private sector. We need to embrace that reality when we think about scaling the system so that it’s truly universal.
Tim Evans, Senior Director of Health, Nutrition and Population,World Bank, by video message
Irrespective of increasing political commitments and global awareness on the harm that NCDs bring from epidemiological, health and economic perspectives, the funding of NCD response as part of development assistance for health continues to be almost negligible.
Téa Collins, Adviser, Global Coordination Mechanism on NCDs, WHO
22 | WHO – Copenhagen Report DAY 1
There has to be a political will to really achieve a change.
Pablo Ferreri, Vice Minister of Economy and Finance, Ministry of Finance, Uruguay
It is evident that integrated service delivery platforms provide the opportunity to improve both health outcomes and cost-efficiency of service delivery. Increased evidence also points to multiple benefits of integration across NCDs and infectious disease programmes. Strengthening the governance function of the national health system is key for ensuring an integrated approach to planning, programming, funding and implementation of national disease control programmes.
George Shakarishvili, Senior Adviser, Health Systems, Global Fund
23 DAY 1
Globally, we are facing difficulties in making the economic and business case for investing in NCDs prevention and control: only few donors “invest” in NCDs, preferring vertical programmes focusing on diseases which show quick results and wins.
Erika Placella, Health Adviser, Swiss Agency for Development and Cooperation
In 2010, Denmark hosted a conference on the burden of NCDs in developing countries here in Copenhagen. Back then it was a challenge to ensure participation of donors, as these were only interested in dealing with challenges that were relevant in developing countries and NCDs were not part of that agenda. Five years later NCDs were included in the SDGs. Today we all agree on this challenge, and we should remember that we have come a long way in the establishment of a joint global agenda towards the elimination of NCDs.
Sanne Frost Helt, WHO Global Coordination Mechanism on NCDs Working Group Co-chair
24 | WHO – Copenhagen Report DAY 1
Without doubt the aspirations of the NCD advocacy community will be stifled if we are not able to unlock the funding required to drive action at a national level. WHO’s efforts to galvanize action in this area are critical if we want to make progress in delivering the 2025 NCD targets.
Cary Adams, Chief Executive Officer, Union for International Cancer Control
25 DAY 2
Plenary session 3 Exploring synergies between financing national NCD responses and broader health systems strengthening efforts for universal health coverage: launch of the report of the Lancet Taskforce on NCDs and economics
Day 2 commenced with the launch of the long-anticipated series on NCDs by the Lancet Taskforce on NCDs and economics. The new series enriches the discussion with arguments and insights on why investing in health, and particularly NCDs, is economically beneficial. The panellists agreed that the most sustainable means of achieving universal health coverage (including prevention and treatment of NCDs) is mandatory prepayment. Price policies and taxation are effective means of reducing NCD risk factors, such as tobacco and unhealthy diet, and can reduce inequalities. Investment in NCD control also results in increased economic growth. The third plenary session was followed by a round of parallel sessions. In an interactive format of six partnership forums focused on six different NCD-related topics, participants were invited to reflect on the overarching financing theme.
26 | WHO – Copenhagen Report DAY 2
Follow-up on the commitments made in 2011 has been a failure by the world community, as sufficient funding has not been allocated.
Adolfo Rubinstein, Minister of Health, Argentina
What’s great about this meeting is that the discussions have been focusing on action.
Jennifer Sargent, Senior Editor, the Lancet
27 DAY 2
Financing for NCDs is no different than financing for other major health needs: it increases equity, improves productivity, and must be part of universal health coverage.
Rachel Nugent, Vice President, Global Noncommunicable Diseases, RTI International
Noncommunicable diseases are often thought of as being too costly to tackle in low- and middle-income countries. But for as little as $1 per person, per year, countries can implement the NCD “best buys” and move substantially toward the SDG targets, whilst seeing huge social and economic benefits. We need to change the way we think about NCDs and see action as an investment for the future, not simply as a cost.
Melanie Bertram, Technical Officer, Economic Analysis and Evaluation, WHO
28 | WHO – Copenhagen Report DAY 2
Plenary session 4 Summary of key outcomes
The fourth plenary session convened to summarize and discuss the key outcomes of the partnership forums, the information from which is reflected in the report recommendations.
DAY 3
Plenary session 5 Synthesis: summary, conclusion and recommendations
The third day started with a plenary discussion summarizing the outcomes of the Global Dialogue.
Several key issues were highlighted:
• The current rate of decline in premature mortality • NCDs represent a strong investment opportunity, from NCDs is not sufficient to meet SDG target with high returns on investment. 3.4 by 2030, and political action needs to be accelerated in 2018. • Successful experiences on NCD financing exist, but there is a need to understand what models • NCD financing is an issue that requires urgent would work in different contexts. Implementation attention. Public resources are not sufficient science can help address this issue. to overcome the NCD challenge. Incentives are needed for the private sector to support financing • More focus should be placed on figuring out how of national NCD responses. Development we make the different sectors and stakeholders assistance will continue to be an important source collaborate. of catalytic funding in low-income countries.
• In rich and poor countries alike, most premature The detailed summary of the Global Dialogue outcomes deaths from NCDs can be prevented or delayed and recommendations are provided in the dedicated by implementing the WHO “best buys” and other sections of this report. recommended interventions for the prevention and control of NCDs through multistakeholder and multisectoral action.
29 DAY 3
The type of research, the type of advice that we should focus on is how. How do we collaborate?
Ilona Kickbusch, Director of the Global Health Centre, Graduate Institute of Geneva
The distinction between the private and public sector is passé – we need to think in terms of partnerships now.
Rifat Atun, Professor of Global Health Systems, Harvard University
30 | WHO – Copenhagen Report DAY 3
It’s not just about sustainable investments, it is also about smarter financing.
Katie Dain, Chief Executive Officer, NCD Alliance
Designing and implementing effective public policies, including health policies, should be embedded in a human rights-based approach (including non-discrimination, data collection, participation, monitoring and accountability). Financing (or resource mobilization and allocation), as well as regulation, including fiscal measures, is a key tool for implementation of the State responsibility to fulfil the right to health. It is not possible to achieve equitable and sustainable development without the fulfilment of basic human rights.
Cristina Gonzalez, Minister Counsellor, Permanent Mission of Uruguay to the United Nations Office and other International Organizations at Geneva
31 DAY 3
Are we actually a good investment? When you talk to investors, don’t ask them for money. Ask them what data and information they need to see the value.
Celina Gorre, Executive Director, Global Alliance for Chronic Diseases
It’s not a question whether, but how we should work with the private sector.
David Clarke, Health Systems Adviser, Law and Governance, WHO
32 | WHO – Copenhagen Report DAY 3
We know that multisectoral and multistakeholder partnerships, within countries and through international collaboration, are needed to mobilize necessary resources. It is hence very timely and critical that the WHO Global Dialogue on Partnerships for Sustainable Financing of NCD Prevention and Control is convened at this moment in time when the world is preparing to achieve the best possible outcomes of the United Nations high-level meeting.
Bent Lautrup-Nielsen, Senior Adviser, World Diabetes Foundation
33 DAY 3
Plenary session 6 Multistakeholder and multisectoral action: a means to unlock financing for NCDs
In the last plenary session it was concluded that NCDs represent a strong investment opportunity, with high returns on investment. When it comes to funding, traditional financing methods and public–private partnerships are critical for mobilizing resources, but innovative and alternative sources and partnership modalities for collaboration and comprehensive NCD prevention and control need to be considered as well. Comprehensive NCD responses require greater policy coherence for development effectiveness and policy harmonization across both aid and non-aid sectors; development outcomes cannot be attributed to any one actor or intervention.
34 | WHO – Copenhagen Report DAY 3
This meeting has had critical aspects that will advise the United Nations high-level meeting on the importance of addressing the NCD challenge, a challenge that needs to be faced rapidly if we wish to achieve the SDGs. It is OK that various intentions and interests are behind the involved partners and stakeholders – the important thing is pulling in the same direction.
Nikolaj Gilbert on behalf of Grete Faremo, Under-Secretary-General and Executive Director, UNOPS
Governments need to think on multistakeholder and multisectoral action when establishing partnerships for addressing NCDs.
Sania Nishtar, Founder and President, Heartfile, by video message
35 DAY 3
If we are to achieve the SDGs we must dare to experiment and think big – and we must not be afraid to work together in new partnership models.
Kristian Jensen, Minister of Finance, Denmark
We cannot solve this problem through philanthropy alone.
This is a momentous conference for the NCD agenda and should mark a paradigm shift for taking the agenda forward.
H.R.H. Princess Dina Mired, Jordan
36 | WHO – Copenhagen Report PROGRAMME OF MEETING
MONDAY, 9 APRIL 2018 MONDAY, 9 APRIL 2018 09:00–10:00 10:30–12:00
Opening ceremony Plenary 1 Setting the stage: the role of partnerships Chair/moderator: and innovative financing to accelerate national Martin Bille Hermann, State Secretary for Development NCD responses Policy, Denmark Chair/moderator: Speakers: Martin Bille Hermann, State Secretary for Development H.R.H. Crown Princess Mary of Denmark Policy, Denmark Ulla Tørnæs, Minister for Development Cooperation, Francesco Branca, Director, Nutrition for Health Denmark and Development, WHO Svetlana Akselrod, Assistant Director-General, WHO Keynote speaker: Bente Mikkelsen, Director a.i., Division of Noncommunicable Diseases and Promoting Health Rifat Atun, Professor of Global Health Systems, through the Life-course, WHO Harvard University* Dina Tadros, Youth Representative* Speakers:
Organized by: Thomas Cueni, Director-General, IFPMA Téa Collins, Adviser, Global Coordination Mechanism Adolfo Rubinstein, Minister of Health, Argentina on NCDs, WHO Agnes Soucat, Director for Health Systems, Governance and Financing, WHO Rapporteur: Francine H.K. Ouedraogo Douamba, Ministry of Health, Line Neerup Handlos, Consultant, WHO Burkina Faso Waleed Almanea, Ministry of Health, Bahrain
Organized by: Daniel Míc, Consultant, WHO Téa Collins, Adviser, Global Coordination Mechanism on NCDs, WHO
Rapporteur: Jakob Sloth Madsen, Senior Programme Manager, World Diabetes Foundation
* indicates those acting as facilitator of technical session
37 PROGRAMME OF MEETING
MONDAY, 9 APRIL 2018 MONDAY, 9 APRIL 2018 13:00-15:00 15:30–17:30
Plenary 2 Parallel session 2.1 Development cooperation for NCDs: aligning Mobilizing resources for a joint United Nations and leveraging domestic and external resources system response to NCDs: the role to achieve SDG target 3.4 of development cooperation
Chair/moderator: Chair/moderator: Téa Collins, Adviser, Global Coordination Mechanism Nicholas Banatvala, Manager, United Nations on NCDs, WHO Interagency Task Force (UNIATF)
Speakers: Speakers: Sanne Frost Helt, WHO GCM/NCD Working Group Thomas Bollyky, Senior Fellow, Council on Foreign Co-chair* Relations* Erika Placella, Health Adviser, Swiss Agency for Douglas Webb, Team Leader, Health, Gender and Development and Cooperation Environment, United Nations Development Programme Cary Adams, Chief Executive Officer, (UNDP) Union for International Cancer Control Adolfo Rubinstein, Minister of Health, Argentina George Shakarishvili, Senior Adviser, Health Systems, Carlotta Barcaro, Corporate Research Manager, Global Fund to Fight AIDS, TB and Malaria United Nations Children’s Fund (UNICEF) Pablo Ferreri, Deputy Minister of Finance, Uruguay Eduardo Zubizarreta, Section Head, International Olayemi Cardoso, Chairman, Citibank, Nigeria* Atomic Energy Agency (IAEA) Tim Evans, Senior Director of Health, Nutrition May Abdel-Wahab, Director, Division of Human Health, and Population, World Bank (video message) Department of Nuclear Applications, IAEA Stineke Oenema, Coordinator, United Nations Standing Organized by: Committee on Nutrition (UNSCN) Téa Collins, Adviser, Global Coordination Mechanism Anselm Hennis, Director, Department of on NCDs , WHO Noncommunicable Diseases and Mental Health, Pan American Health Organization (PAHO)/WHO WHO Rapporteur: Regional Office for the Americas Mads Loftager, Senior Programme Manager, World Diabetes Foundation Organized by: Alexey Kilukov, External Relations Officer, UNIATF, WHO Nick Banatvala, Manager, UNIATF, WHO
Rapporteur: Kirza Kristensen, Senior Adviser, World Diabetes Foundation
* indicates those acting as facilitator of technical session
38 | WHO – Copenhagen Report PROGRAMME OF MEETING
MONDAY, 9 APRIL 2018 MONDAY, 9 APRIL 2018 15:30–17:30 15:30–17:30
Parallel session 2.2 Parallel session 2.3 Mobilizing domestic resources for NCDs: How to harness the power of the private sector learning from country experiences to implement national NCD responses
Co-moderators: Chair/moderator: Kristina Mauer-Stender, Programme Manager, Vanessa Candeias, Head of Global Health Tobacco Control, WHO and Healthcare Initiative, World Economic Forum Fernando Araujo, Secretary of State for Health, Bent Lautrup-Nielsen, Senior Adviser, Portugal World Diabetes Foundation
Speakers: Speakers: Carlos Eduardo de Oliveira Lula, Secretary of Health David Clarke, Health Systems Adviser, of State of Maranhão, Ministry of Health, Brazil Law and Governance, WHO Agnes Soucat, Director for Health Systems, Governance Stéphane Besançon, Chief Executive Officer, and Financing, WHO Santé Diabète Oxana Domenti, Parliament of Republic of Moldova Andrea Atzori, Head of International Relations, Tanel Ross, Adviser, Ministry of Finance, Estonia Doctors with Africa Cuamm Jeremias Paul, Coordinator, Tobacco Control, WHO Kaushik Ramaiya, General Secretary, Tanzania Diabetes Association
Organized by: Niels Lund, Delegate, IFPMA Marge Reinap, Head of Country Office, WHO Estonia Amy Israel, Delegate, IFPMA
Rapporteur: Organized by: Amelie Keller, WHO Regional Office for Europe Vanessa Candeias, Head of Global Health and Healthcare Initiative, World Economic Forum Bent Lautrup-Nielsen, Senior Adviser, World Diabetes Foundation
Rapporteurs: Elsa Morandat, Programme Manager, World Diabetes Foundation Susanne Olejas, Programme Manager, World Diabetes Foundation
39 PROGRAMME OF MEETING
MONDAY, 9 APRIL 2018 TUESDAY, 10 APRIL 2018 15:30–17:30 09:00-11:00
Parallel session 2.4 Plenary 3 Measuring resource flows into NCDs: current Exploring synergies between financing national trends and projections NCD responses and broader health systems strengthening efforts for universal health Chair/moderator: coverage: launch of the report of the Lancet Dorje Mundle, Expert* Taskforce on NCDs and economics
Speakers: Chair/moderator: Brenda Killen, Deputy Director, OECD Jennifer Sargent, Senior Editor, the Lancet* Rachel Nugent, Vice President, Global Non- Communicable Diseases, RTI International* Speakers: Hafeez Ladha, Director, Innovative Finance, Financing Rachel Nugent, Vice President, Global Non- Alliance for Health Communicable Diseases, RTI International* Harald Nusser, Delegate, IFPMA Franco Sassi, Professor of International Health Policy and Economics, Imperial College Business School* Eduardo Banzon, Principal Health Specialist, Asian Development Bank Adolfo Rubinstein, Minister of Health, Argentina Stephen Jan, Professor of Health Economics, Organized by: University of New South Wales* Andrea Feigl, Health Economist, OECD Hans Kluge, Director, Division of Health Systems and Public Health, WHO
Rapporteur: Mark Pearson, Deputy Director, Employment, Labour and Social Affairs, OECD Andrea Feigl, Health Economist, OECD Melanie Bertram, Technical Officer, Economic Analysis and Evaluation, WHO
Organized by: Rachel Nugent, Vice President, Global Non- Communicable Diseases, RTI International*
Rapporteur: Mads Loftager, Senior Programme Manager, World Diabetes Foundation
* indicates those acting as facilitator of technical session
40 | WHO – Copenhagen Report PROGRAMME OF MEETING
TUESDAY, 10 APRIL 2018 TUESDAY, 10 APRIL 2018 11:30-13:30 11:30-13:30
Parallel session 3.1 Parallel session 3.2 Political economy of universal health coverage Investing in innovative service delivery models for NCDs: what are the necessary economic, towards integrated person-centred care social and political preconditions to make for NCDs universal health coverage for NCDs a realistic goal for all? Chair/moderator: Bent Lautrup-Nielsen, Senior Adviser, Chair/moderator: World Diabetes Foundation Celina Gorre, Executive Director, Global Alliance for Chronic Diseases Speakers: Sanne Frost Helt, WHO GCM/NCD Working Group Speakers: Co-chair* Adolfo Rubenstein, Minister of Health, Argentina Jonathan Klein, Immediate Past-Chair, NCD Child Joao Rodrigues Da Silva Breda, Head, Integrated Kaushik Ramaiya, General Secretary, Prevention and Control of NCDs, WHO Tanzania Diabetes Association Vilma Irazola, Director, Centre of Excellence in Simon Barquera, Director, Centre for Nutrition and Cardiovascular Health in South America, Institute Health, National Institute of Public Health, Mexico of Effective Clinical Health Care, Argentina Gene Bukhman, Director, Harvard Medical School Madiha Ahmed, Senior Program Specialist, International Development and Research Centre, Organized by: Canada Bent Lautrup-Nielsen, Senior Adviser, World Diabetes Foundation Organized by:
Celina Gorre, Executive Director, Global Alliance Rapporteurs: for Chronic Diseases Elsa Morandat, Programme Manager, World Diabetes Foundation Rapporteur: Susanne Olejas, Programme Manager, Elizaveta Lebedeva, Consultant, WHO World Diabetes Foundation
41 PROGRAMME OF MEETING
TUESDAY, 10 APRIL 2018 TUESDAY, 10 APRIL 2018 11:30-13:30 11:00-13:30
Parallel session 3.3 Parallel session 3.4 Building the investment case for NCD prevention Cost-effective and feasible solutions: and control WHO “best buys”
Chair/moderator: Chair/moderator: Nick Banatvala, Manager, UNIATF Mary-Anne Land, Technical Officer, WHO
Speakers: Speakers/panellists: Douglas Webb, Team Leader, Health, Gender and Melanie Bertram, Technical Officer, Economic Analysis Environment, UNDP and Evaluation, WHO Rachel Nugent, Vice President, Global Non- Dian Black, Acting Deputy Financial Secretary, Ministry Communicable Diseases, RTI International* of Finance and Public Service, Jamaica Andrea Feigl, Health Economist, OECD Frederico Bosco Alves dos Santos, Head of Department Katie Dain, Chief Executive Officer NCD Alliance for NCD, Ministry of Health, Timor-Leste Stineke Oenema, Coordinator, UNSCN Justice Mudavanhu, Deputy Director, Non- Communicable Diseases, Ministry of Health, Zimbabwe Purwanto Purwanto, Director of Budget, Human and Culture Development, Ministry of Finance, Indonesia Gwenael Dhaene, Health Systems Adviser, WHO Robert Tripp, Senior Adviser, Framework Convention Ajitha Botagoda, Director, Ministry of Finance and Mass on Tobacco Control Media, Sri Lanka Thaksaphon Thamarangsi, Director, Noncommunicable Organized by: Diseases and Environmental Health, WHO Nick Banatvala, Manager, UNIATF Organized by:
Rapporteur: Mary-Anne Land, Technical Officer, WHO Jakob Sloth Madsen, Senior Programme Manager, World Diabetes Foundation Rapporteur: Hanne Strandgaard, Head of Programme Department, World Diabetes Foundation
* indicates those acting as facilitator of technical session
42 | WHO – Copenhagen Report PROGRAMME OF MEETING
TUESDAY, 10 APRIL 2018 TUESDAY, 10 APRIL 2018 14:30–16:30 14:30–16:30
Partnership forum 1 Partnership forum 2 Scaling up digital health for NCDs: NCDs and mental health in emergencies: leaving no one behind beyond current financing
Chair/moderator: Chair/moderator: Mary-Anne Land, Technical Officer, WHO Daniel Hugh Chisholm, Programme Manager, Mental Health, WHO Speakers: Fiona Adshead, Deputy Chief Executive, NCD Alliance Speakers: Clayton Hamilton, Unit Leader, WHO Sarah Harrison, Technical Adviser, International Federation of Red Cross and Red Crescent Societies Thomas Cueni, Director-General, IFPMA Erika Placella, Health Adviser, Swiss Agency Birgit Morlion, Programme Officer, eHealth, Well-being for Development and Cooperation and Ageing, European Commission Birgitte Bischoff Ebbesen, Director, International Pasqualino Procacci, Head, Human Development Department, Danish Red Cross Office, Agency for Development Cooperation, Italy Slim Slama, Regional Adviser, WHO
Organized by: Organized by: Marta Guglielmetti, Government Relations and Partnerships, WHO Slim Slama, Regional Adviser, WHO Mary-Anne Land, Technical Officer, WHO Rapporteur:
Rapporteur: Line Neerup Handlos, Consultant, WHO Kirza Kristensen, Senior Adviser, World Diabetes Foundation
43 PROGRAMME OF MEETING
TUESDAY, 10 APRIL 2018 TUESDAY, 10 APRIL 2018 14:30-16:30 14:30-16:30
Partnership forum 3 Partnership forum 4 A vital investment: scaling up health workforce Accelerating access to medicines and new for NCDs technologies in low- and middle-income countries: viable models for innovative Chair/moderator: partnerships Francesca Celletti, Vice President, Corvus Health Chair/moderator: Speakers/panellists: Helen McGuire, Global Program Leader, PATH Isabel Jacinto, Pharmacist, National Association of Pharmacies, Portugal Speakers: Sanne de Wit, Liaison Officer for Public Health James Pfitzer, Director, Access Accelerated, IFPMA* Issues, International Federation of Medical Students’ Soraya Ramoul, Delegate, IFPMA Associations Gerald Mutungi, Programme Manager, Non- Andreas Rudkjøbing, World Medical Association Communicable Diseases (NCDs) Prevention Council, World Medical Association and Control Programme, Ministry of Health, Uganda Feven Girma Assefa, Ministry of Health, Ethiopia Dorcas Kiptui, Head, Tobacco Control Unit, Ministry Patrick Kupelian, Vice President, Varian Medical of Health, Kenya Systems* Helen McGuire, Global Program Leader, PATH Kaushik Ramaiya, General Secretary, Organized by: Tanzania Diabetes Association Baptiste Vasey, Fellow, Mercator Fellowship* Julia Tainijoki Seyer, Medical Adviser, World Medical Organized by: Association James Pfitzer, Director, Access Accelerated, IFPMA* Vanessa Peberdy, Manager, Global Health Policy, IFPMA Rapporteur: Baptiste Vasey, Fellow, Mercator Fellowship* Rapporteurs: Helen McGuire, Global Program Leader, PATH Grega Kumer, Head, Director-General Office, IFPMA
* indicates those acting as facilitator of technical session
44 | WHO – Copenhagen Report PROGRAMME OF MEETING
TUESDAY, 10 APRIL 2018 TUESDAY, 10 APRIL 2018 14:30–16:30 14:30–16:30
Partnership forum 5 Partnership forum 6 Advocacy for resource mobilization for NCDs: Creating a shared value: aligning commercial the role of civil society for holding stakeholders and public health interests to tackle NCDs accountable Chair/moderator: Chair/moderator: Ilona Kickbusch, Director, Global Health Centre, Katie Dain, Chief Executive Officer, NCD Alliance Graduate Institute, Geneva*
Speakers: Speakers: Stéphane Besançon, Chief Executive Officer, David Clarke, Health Systems Adviser, Law and Santé Diabète Governance, WHO Stefan Islandi, Director of Development, Danish Dorje Mundle, Expert* Cancer Society Franck Droin, President, European Association Tih Ntiabang, Regional Coordinator, WHO Regional of Paritarian Institutions Office for Africa, Framework Convention Alliance, Rachel Melsom, Tobacco Free Portfolios Cameroon Martin Bernhardt, Delegate, IFPMA Ishu Kataria, Public Health Researcher, Young Professionals Chronic Disease Network Organized by: Luis Manuel Encarnaciòn Cruz, Youth Innovation Lab Sophie Genay-Dillautas, Technical Officer, WHO Baptiste Vasey, Fellow, Mercator Fellowship* Organized by: Priya Kanayson, Senior Advocacy Officer, NCD Alliance Rapporteur: Mary-Anne Land, Technical Officer, WHO Elizaveta Lebedeva, Consultant, WHO
Rapporteur: Priya Kanayson, Senior Advocacy Officer, NCD Alliance
45 PROGRAMME OF MEETING
TUESDAY, 10 APRIL 2018 WEDNESDAY, 11 APRIL 2018 17:00-18:00 09:00-10:30
Plenary 4 Plenary 5 Debriefing from partnership forums: current Synthesis: summary, conclusion and and new financing models, partnerships, recommendations mechanisms, policies and frameworks Chair/moderator: Chair/moderator: Ilona Kickbusch, Director, Global Health Centre, Franco Sassi, Professor of International Health Policy Graduate Institute, Geneva* and Economics, Imperial College Business School* Speakers: Speakers: Cristina Gonzalez, Minister Counsellor, Permanent Clayton Hamilton, Unit Leader, WHO Mission of Uruguay to the United Nations Office Slim Slama, Regional Adviser, Noncommunicable and other International Organizations at Geneva Diseases Prevention,WHO Katie Dain, Chief Executive Officer, NCD Alliance Baptiste Vasey, Fellow, Mercator Fellowship* Celina Gorre, Executive Director, Global Alliance for Helen McGuire, Global Program Leader, PATH Chronic Diseases* Katie Dain, Chief Executive Officer, NCD Alliance David Clarke, Health Systems Adviser, Law and Governance, WHO Rachel Melsom, Director, UK and Europe, Tobacco Free Portfolios Jennifer Healy, Chief of Staff, Department of Health and Human Services, United States of America Bent Lautrup-Nielsen, Senior Adviser, World Diabetes Foundation Kaushik Ramaiya, General Secretary, Tanzania Diabetes Association
Organized by: Rifat Atun, Professor of Global Health Systems, Harvard University* Baptiste Vasey, Fellow, Mercator Fellowship* Nick Banatvala, Manager, UNIATF
Rapporteur: Organized by: Dina Tadros, Youth Representative* Dina Tadros, Youth Representative* Téa Collins, Adviser, Global Coordination Mechanism on NCDs, WHO
Rapporteur: Bent Lautrup-Nielsen, Senior Adviser, World Diabetes Foundation
* indicates those acting as facilitator of technical session
46 | WHO – Copenhagen Report PROGRAMME OF MEETING
WEDNESDAY, 11 APRIL 2018 WEDNESDAY, 11 APRIL 2018 11:00–12:30 12:30–13:00
Plenary 6 Call to action and closure Multistakeholder and multisectoral action: of the meeting a means to unlock financing for NCDs Speakers/co-organizers: Chair/moderator: Martin Bille Hermann, State Secretary for Development Guy Fones, Acting Head, Secretariat of the WHO Policy, State Secretary for Development Policy, Global Coordination Mechanism on Noncommunicable Denmark Diseases, WHO Bente Mikkelsen, Director, Division of Noncommunicable Diseases and the Promotion Keynote speakers: of Health through the Life Course (A.I), WHO Nikolaj Gilbert, United Nations Office for Project Services (UNOPS) Kristian Jensen, Minister of Finance, Denmark
Speakers: H.R.H. Princess Dina Mired, Union for International Cancer Control Bente Mikkelsen, Director a.i., Division of Noncommunicable Diseases and Promoting Health through the Life-course, WHO Bagher Larijani, Deputy for Education and Vice President of Non-Communicable Diseases, Ministry of Health and Medical Education, Islamic Republic of Iran Raquel Rosa, Director-General of Health, Ministry of Health, Uruguay James Love, Director, Knowledge Ecology International Mohammed Hamad Al Thani, Director of Public Health, Ministry of Public Health, Qatar Sania Nishtar, Co-chair, WHO Independent High-level Commission on NCDs (video statement)
Organized by: Guy Fones, Acting Head, Secretariat of the WHO Global Coordination Mechanism on Noncommunicable Diseases, WHO
Rapporteur: Jakob Sloth Madsen, Senior Programme Manager, World Diabetes Foundation
47 48 | WHO – Copenhagen Report Global Dialogue outcomes
03 3.1 HIGH-LEVEL SUMMARY
The WHO Global Dialogue on Partnerships for Sustainable The third United Nations General Assembly High-level Financing of Noncommunicable Disease Prevention and Meeting on NCDs, taking place in September 2018, will call Control, hosted by the Government of Denmark, brought on global leaders to reflect on the financial investments together WHO Member States, United Nations system necessary to accelerate progress of national NCD responses organizations, and non-State actors to explore new ways by 2030. As an input into deliberations around these to address the critical gap in financing of national NCD investments, the Global Dialogue highlighted the urgent responses. need for governments, development partners, United Nations During the course of the Dialogue, participants reviewed system organizations and all relevant stakeholders to prioritize the progress made since 2011 in the provision of funding for NCDs as an essential pillar of sustainable development national NCD responses through domestic, bilateral and and an integral part of countries’ efforts towards universal multilateral channels. They emphasized the importance of health coverage. strong and continuous national leadership by Heads of State and Government to significantly raise investments in NCD Some of the key messages heard at the Global Dialogue prevention and control to support the realization of target 3.4 were the following: of Sustainable Development Goal 3 – to reduce by one third premature mortality from NCDs by 2030 though prevention and treatment, and promote mental health and well-being. • Reaching SDG target 3.4 in low- and middle- income countries will require bold changes in the way countries finance the development and The Global Dialogue highlighted implementation of national NCD responses. the urgent need for governments, • Two high-level meetings on NCDs raised political development partners, United awareness of the problem, but did not trigger sufficient resource mobilization to translate the Nations system organizations high-level political commitments into accelerated and all relevant stakeholders to country-level action. prioritize NCDs as an essential • Unless political action is accelerated in 2018, current rates of investments are not sufficient to meet SDG pillar of sustainable development. target 3.4 by 2030.
NCDs (including cardiovascular diseases, cancer, chronic • Premature mortality from NCDs is avoidable through obstructive pulmonary disease, diabetes and mental a combination of population-based and individual conditions) and their shared risk factors (tobacco use, harmful health measures ensured through universal health use of alcohol, unhealthy diets and physical inactivity, as well coverage of primary and secondary prevention, as air pollution) represent a hurdle to sustainable development treatment and rehabilitation. due to their negative impact on macroeconomic productivity, national growth, health care costs and household incomes. • Most countries have the capacity to mobilize Every year, over 40 million deaths globally are due to NCDs. sufficient domestic resources for comprehensive The high level of premature mortality from NCDs – that NCD prevention and control through improved tax is, deaths between the ages of 30 and 70 – is particularly systems and innovative financing mechanisms. alarming, killing women and men when they are most When allocated efficiently and equitably, greater productive. According to WHO, 15 million people died investments in health will result in lower health care prematurely from NCDs in 2016, and 85%, or 13 million, of costs in the long term. these deaths took place in low- and middle-income countries.
50 | WHO – Copenhagen Report In particular, the Global Dialogue stressed the need:
• Domestic financing alone will not be sufficient in • for governments to exercise bold political leadership countries with limited resources to finance national to increase domestic resources for comprehensive NCD responses and strengthen health systems. NCD prevention and control and embrace universal Therefore, catalytic development assistance for health coverage as an integrated approach for health will be required to complement other sources measuring progress towards SDG target 3.4; of funding. • to expand the fiscal space for health through an • While governments have the primary role and increase in general tax revenues, improved efficiency responsibility for responding to the challenge of and equity, and better prioritization of health in NCDs, incentives will be needed for the private sector public sector budgets; to support financing of national NCD responses. However, governments should pay due diligence in • to create an enabling legal and regulatory order to avoid any potential or perceived conflicts of environment conducive to the implementation of interest and maximize the public health benefits. evidence-based, cost-effective NCD interventions, such as the WHO Global NCD Action Plan “best buys” • The interlinked 2030 Agenda for Sustainable and other recommended interventions; Development cannot be implemented without policy coherence across sectors and multisectoral, • to complement domestic resources with international multistakeholder partnerships, as well as the actions, cooperation, including official development resources, knowledge, and expertise of non-State assistance and other resources, with a focus on least and international actors to complement the efforts developed countries, to increase health expenditure of governments. Reaching SDG target 3.4 in low- and on prevention and control of NCDs, consistent with middle-income countries will require bold changes country needs and priorities; in the way countries finance the development and implementation of national NCD responses. • to promote and incentivize innovative and bold partnerships comprising financing and engagement of relevant non-State actors, including the Therefore, in the lead-up to the Third High-level Meeting on private sector in public–private partnerships the Prevention and Control of NCDs, the Dialogue elevated the and philanthropies, to mobilize additional funds need for bold action by governments, health and development to address NCDs, while respecting country agencies and relevant non-State actors, taking into account policies and priorities, and considering adequate national realities, capacities, priorities, needs and levels management of conflicts of interest for the of development, to ensure that no one is left behind. protection of public health.
51 3.2 COPENHAGEN GLOBAL DIALOGUE RECOMMENDATIONS FOR ACCELERATING NATIONAL NCD RESPONSES
The Global Dialogue recommendations are organized around the main themes of each plenary and operationalize the statements included in the high-level summary of the Global Dialogue.
The role of partnerships and innovative Development cooperation for NCDs: financing to accelerate national aligning and leveraging external and NCD responses domestic resources to achieve SDG target 3.4 From high-level summary From high-level summary
• Promote and incentivize innovative and bold partnerships comprising financing and engagement • Complement domestic resources with international of relevant non-State actors, including the cooperation, including official development private sector in public–private partnerships and assistance and other resources, with a focus on least philanthropies, to mobilize additional funds to developed countries, to increase health expenditure address NCDs, while respecting country policies on prevention and control of NCDs, consistent with and priorities, and considering adequate country needs and priorities. management of conflicts of interest for the protection of public health. • Expand the fiscal space for health through an increase in general tax revenues, improved efficiency and equity, and better prioritization of health in Recommendations public sector budgets.
• Governments should mobilize private investments for the financing of national NCD responses, including through Recommendations public–private partnerships, in order to accelerate the implementation of the 2030 Agenda for Sustainable External finance Development and attain SDG target 3.4. • High-income countries should commit to contribute • Governments need to establish sound national statutory at least 0.15% of gross domestic product (GDP) to and regulatory frameworks to enable more concrete development assistance to health and establish clear, contributions from the diverse range of private sector well defined and publicly available criteria for the entities to NCD prevention and control. allocation of resources with inputs from key relevant stakeholders, including civil society. • Global public–private partnerships (e.g. the Global Fund, Gavi, the Vaccine Alliance, and UNITAID) with • Development partners should align their support existing innovative financing models should build with recipient countries’ national multisectoral NCD on their experience and make space for NCDs in plans and strategies and strengthen the capacity providing a comprehensive package that includes of ministries of health to facilitate multisectoral NCD-related interventions. and multistakeholder action for SDG target 3.4.
2 McIntytre D, Meheus F, Rottingen J. What level of domestic government health expenditure should we aspire to for universal health coverage? Health Economics, Policy and Law. 2017;12(2):125–37.
52 | WHO – Copenhagen Report • Governments should consider pooling external resources for health (including from the Global Fund, Gavi, the Vaccine Alliance, and the World Bank) and allocating funds to prevention and control of NCDs and their risk factors proportionate to the national NCD disease burden.
• Governments should recognize official development assistance for NCDs as a catalyst to mobilize domestic resources, both public and private, for the prevention and control of NCDs.
• Governments should develop NCD investment cases demonstrating high return on investment for NCD prevention and control in order to ensure prioritization and scale-up of NCD interventions.
• Governments should secure low-interest loans from financial institutions to address the NCD needs of vulnerable populations (e.g. refugees, pregnant women and children, the elderly, the poor and stigmatized communities).
Domestic finance Governments should devote at least • Governments should devote at least 5% of GDP to health and 5% of GDP to health and ensure ensure government expenditure per capita of at least US$ 86. government expenditure per capita Middle-income countries should be able to reach these targets of at least US$ 86. without external assistance.2
• Governments should generate domestic revenues for health through improved and innovative taxation (e.g. financial transaction taxes).
• Excise taxes on tobacco, alcohol, sugar and carbon emissions, combined with measures to improve tax administration, reduce the consumption of these harmful products, improve public health and generate revenues at the same time.
• To increase government spending on health and other social sectors (underlying social determinants for NCDs), and ensure the implementation of the WHO “best buys” and other recommended interventions, investments are needed to improve tax compliance and administrative capacities.
• Resource-rich countries should consider maximizing their revenue through increasing taxation on natural resources and reducing subsidies on harmful products (e.g. fossil fuels) to spend on health and prevent NCDs.
According to WHO, 15 million people died prematurely from NCDs in 2016, and 85%, or 13 million, of these deaths took place in low- and middle-income countries.
53 Exploring synergies between financing • Governments, in consultation with civil society and national NCD responses and broader international partners, should establish a formal priority- health systems strengthening efforts setting process for the allocation of health resources, including NCDs, that can energize and offer significant for universal health coverage co-benefits to other areas of public health, such as maternal and child health, communicable diseases, health From high-level summary systems strengthening, and the social and environmental determinants of health.
• Governments exercise bold political leadership to • Governments should ensure that catastrophic out-of-pocket increase domestic resources for comprehensive NCD expenditure due to NCDs, driving households into poverty, prevention and control and embrace universal health is minimized, with out-of-pocket expenditure not exceeding coverage as an integrated approach for measuring 20% of total health expenditure, and no out-of-pocket progress towards SDG target 3.4. expenditure for priority NCD services for the poor and other vulnerable groups. • Create an enabling legal and regulatory environment conducive to the implementation of evidence-based, • Governments should ensure the establishment of mandatory cost-effective NCD interventions, such as the WHO prepaid pooled funds for universal health coverage with Global NCD Action Plan “best buys” and other full population coverage of comprehensive primary care, recommended interventions. including the NCD “best buys” and, where appropriate, other recommended interventions.
• Governments should invest in strengthening legal Recommendations and regulatory capacities, as well as monitoring and data collection systems for accountability and measuring • Governments should reaffirm their commitments made in the results. the Montevideo Roadmap 2018–2030 on Noncommunicable Diseases as a Sustainable Development Priority, and in other • Governments should invest in health workforce development high-level meetings, to significantly increase the financing and improving the overall mix of different professional of national NCD responses and international cooperation groups to ensure continuous and comprehensive NCD through domestic, bilateral and multilateral channels prevention and control. and take action to reduce the impact of NCDs on poverty and development.3
3 Montevideo Roadmap on NC 2018-2030 on NCDs as a Sustainable Development Priority (http://www.who.int/conferences/global-ncd-conference/Roadmap.pdf).
54 | WHO – Copenhagen Report 3.3 KEY MESSAGES FROM MULTISTAKEHOLDER AND MULTISECTORAL DIALOGUE AND PARTNERSHIP FORUMS
Parallel session 2.1. Mobilizing • Taxes on tobacco use, harmful use of alcohol and unhealthy resources for a joint United Nations products (especially sugar-sweetened beverages) have system response to NCDs: the role proven to have great public health impact and significant positive potential to yield improved health outcomes, while of development cooperation having the added benefit of mobilizing domestic revenues. These are among the NCD “best buys” approved by the • The United Nations should use its unique mandate to World Health Assembly in 2017. As such, consumption taxes advocate a multisectoral approach and provide technical can be part of a comprehensive financing approach to help support to Member States to develop comprehensive address the funding challenges of national NCD responses. national NCD responses. • Earmarking tax revenues for health purposes can improve • A whole-of-United Nations response is required to support political acceptability for introducing new or increasing tax countries in scaling up their action on NCDs as part of the rates on tobacco and unhealthy products, with revenues 2030 Agenda for Sustainable Development. The NCD-related deployed to support programmes for health behaviour SDG response requires multisectoral action: United Nations change, such as reduced tobacco use, or to cover certain system agencies have significant opportunities to engage underserved populations, conditions, and areas, such as with different parts of government. health promotion.
• Member States are increasingly demanding technical • Involvement of civil society is key. If society is on our side, assistance and expertise to catalyse their national NCD we can win the case. It is important for civil society to responses and to develop sustainable and equitable health understand the importance and benefit of health promotion, systems. and to exercise its potential to influence the political will.
• The United Nations system has shown its ability to provide Parallel session 2.3. How to harness timely and effective support to governments on NCDs but it has the potential to do much more at global, the power of the private sector to regional and country levels. implement national NCD responses
• The United Nations Interagency Task Force on the Prevention • New business models should be based on long-term and Control of NCDs provides an effective platform for commitments and government ownership or endorsement, bringing the United Nations system together to support for example through alignment with national NCD response countries in their efforts to overcome NCDs. frameworks.
Parallel session 2.2. Mobilizing domestic • Private sector engagement can be incentivized by well- defined NCD response frameworks and a verbalized need resources for NCDs: learning from by national stakeholders, while acknowledging “win–win” country experiences perspectives from different angles: public health, as well as commercial. • A comprehensive fiscal dialogue among key stakeholders (especially ministries of health and finance) that includes • Country coordination mechanisms for technical guidance fostering a transparent, evidence-informed budget process to country authorities on managing resource flows and is key for domestic resource mobilization for health and international support towards NCD responses would its successful and sustainable implementation. stimulate platforms for further private sector engagement,
55 while also ensuring adequate governance and control. Parallel session 3.2. Investing in New WHO work on private sector engagement frameworks innovative service delivery models would be instrumental in producing much-needed country- towards integrated person-centred care level guidance. for NCDs • Numerous successful long-term public–private partnerships for NCD response exist whereby philanthropic entities, • Integration of NCDs into existing health programmes the private sector, bilateral development programmes, aims to result in better and more holistic patient care, and national and international civil society organizations prevention and treatment outcomes, while avoiding are supporting governments and ministries of health in duplication of efforts and addressing prevention and implementing national NCD responses. These examples treatment of diseases along with their shared risk factors should be further codified, analysed, disseminated, in a simultaneous and integrated manner. and outlined for scaling up. • Cost-effective and high-impact “best buy” interventions Parallel session 2.4. Measuring resource to prevent and control NCDs are available and, at individual level, they cost next to nothing. In order to flows into NCDs: current trends and ensure that these interventions are delivered in an efficient projections and effective manner and have the desired impact, especially in light of the prevailing economic difficulties, an • Work should be done to understand the role of private integrated approach is necessary. sector resources to support the NCD agenda and the return on the investment. • Integration of NCD with other health initiatives and programmes is a dynamic process with multiple • The HIV/AIDS area offers an informative template for dimensions, and should be a continuous process of undertaking expenditure reviews, which must be carried out context-specific balance between horizontal and vertical at a detailed level. This is not purely a health sector issue, integration of, and linkages and synergies within, health and there is a need to adopt a cross-sectoral approach. services. Different approaches to integration can be used, although integrating NCD interventions into the health Parallel session 3.1. Political economy system based on primary health care remains the best model. of universal health coverage for NCDs: what are the necessary economic, social • Integration of mental health in NCD and other health and political preconditions to make programmes and improving access to mental health care will reduce policy fragmentation, and will create synergies universal health coverage for NCDs in support of achieving SDG target 3.4. a realistic goal for all? Parallel session 3.3. Building the • Successful universal health coverage implementation goes hand in hand with NCD prevention, management investment case for NCD prevention and treatment. and control
• Universal health coverage can only be achieved through • A full investment case consists of an economic analysis a multisectoral needs assessment, and adopting and an institutional context analysis. They are tailor made an evidence-based approach in proposing solutions for each country, using the country’s own epidemiological and implementing appropriate measures. and economic data.
• An emphasis on prevention is required in least • Investment cases have been used with success by developed countries. governments and development partners to articulate the case for mobilizing political commitment and financial • More research and modelling is needed to design optimal resources for health and development, but only recently for universal health coverage plans for each country. NCDs. They are important for demonstrating the return on investment of interventions that prevent and control NCDs.
56 | WHO – Copenhagen Report • The indirect costs of NCDs are generally much higher than • Be He@lthy, Be Mobile is a joint initiative between the the direct costs. The externalities of the health-related costs International Telecommunication Union and WHO created borne directly by the health system are distributed across a following the 2011 United Nations Political Declaration on government’s budget and society. NCDs, which called for more innovations to address chronic disease prevention and management and more public • For diet-related NCDs, investments to support healthier food and private sector partnerships. The initiative supports systems are at hand for countries that wish to implement governments to scale up national mHealth programmes the Framework for Action of the Second International by implementing text-based messaging initiatives, Conference on Nutrition, Rome, 19–21 November 2014. thereby building country capacity for advanced digital Investments to improve nutrition and health range health programmes. Be He@lthy, Be Mobile supports from large-scale infrastructure improvements to small- programmes on a range of disease areas and risk scale technical and marketing support, and should be factors, such as tobacco, cervical cancer, hypertension, complemented by regulatory and voluntary measures, and diabetes, as well as co-morbidities, such as TB and consumer education and incentives. tobacco, and NCDs and healthy ageing. Be He@lthy, Be Mobile provides countries with all necessary information • Public investments should be aligned with other social to plan, implement and maintain an mHealth programme goals. Too often, agricultural and industrial policies ignore from the beginning (through toolkits and continued the social and health implications of their expenditures. country support). Governments are responsible for increasing social well-being and should align investment policies towards that end. Partnership forum 2. NCDs and mental health in emergencies: beyond current Parallel session 3.4. Cost-effective and financing feasible solutions: WHO “best buys” • While it has been acknowledged that NCDs are not just • The “best buys” for NCDs are the most cost-effective a problem of the developed world, but also present a and feasible policies and interventions for countries growing challenge in low- and middle-income countries, to implement. there is still a need to build consensus on the importance of addressing NCDs and mental health in emergencies, • Maximizing the impact of every dollar spent is crucial shaping an agenda of work that reflects the priorities if we are to tackle NCDs. of countries in emergency situations.
• Effective fiscal strategies are required to ensure solid • In addressing NCDs and mental health in emergencies, and sustainable impact. appropriate measures should be integrated into the existing humanitarian landscape, emergency operating Partnership forum 1. Scaling up digital frameworks and procedures across the various phases of the emergency cycle, from preparedness to response to health for NCDs: leaving no one behind recovery.
• Digital technology is an increasingly important element • There is a need to further develop standards, normative of public health. It has significant potential to connect guidance, tools and service packages for NCD new audiences with NCD-related information and services. management in emergencies, drawing on and taking stock of current and past humanitarian responses. • Ensuring equitable digital access will involve new models of collaboration between governments, populations and • The main concern for people affected by NCDs in the private sector. There needs to be greater dialogue emergency settings is the lack of continuity of care. This about the requirements of each in order to help develop can be accommodated by strengthening and scaling solutions that can achieve scale and reach their target up the use of existing primary health care systems in users. Consensus about common standards will help ensure emergency settings, while avoiding, to the extent possible, consistent quality across different interventions. building parallel systems of care for NCDs.
• An accountability framework and indicators should be developed to monitor, evaluate and report on the performance of NCD- and mental health-related emergency responses.
57 Partnership forum 3. A vital investment: Partnership forum 5. Advocacy for scaling up health workforce for NCDs resource mobilization for NCDs: the role of civil society for holding stakeholders • The demand for health workers is expected to increase in the coming years, with a projected shortfall of 18 million accountable health workers, primarily in low- and lower middle-income countries, by 2030. Decent working conditions will attract • Civil society is a key stakeholder in mobilizing resources more health professionals and act as a retention strategy. for NCD prevention and control at all levels – local, national, and global. • Building strategies to address current and anticipated health workforce shortages should start today, and should include • Successes in country must be highlighted at global a step-by-step plan for each specialty, rather than general forums to demonstrate how investing in the prevention principles. Local authorities and individual hospitals can and control of NCDs is cost-effective and implementable, and should be encouraged to develop solutions. and yields returns.
• The collection and analysis of reliable data on human • Civil society is able to mobilize resources in innovative ways, resources for health in terms of needs, demand and supply and create links between NCDs and other sustainable at a national level should be incentivized, as well as ensuring development priorities. the tracking of migration trends for improved planning and accountability. • Lack of data on investment of resources for NCDs makes tracking resource mobilization for NCDs difficult; • Only through a strong health care system with well trained strengthened data collection and monitoring helps and equipped health professionals can we increase the civil society hold governments and other stakeholders health of the population and fight the burden of NCDs. NCD to account. competencies and social accountability should be part of every health professional’s training curriculum. In this regard, Partnership forum 6. Creating a shared it is important to improve the governance of education institutions and to develop regulatory mechanisms for value: aligning commercial and public accreditation and quality assurance, as well as to ensure health interests to tackle NCDs their consistent implementation. • There is a need for a much broader understanding of Partnership forum 4. Accelerating access the range of private sector actors, as well as identification of those whose interest can align with public health to medicines and new technologies in to engage in the ambitious SDG agenda and to create low- and middle-income countries: viable partnership frameworks and incentives that facilitate models for innovative partnerships effective collaboration and can support government performance on NCD prevention and control.
• Barriers to the secure supply of NCD medicines and products • There is a need to work on companies’ strategic and are complex and involve an array of factors, including the profitability goals so they align with public health objectives, adequacy of financial resources, the strength of the health on ethical investment strategies, and on regular reporting system (particularly at the primary care level), supply on the ethical and health dimensions of the global consumer management, and advocacy. These barriers cannot markets, especially in relation to WHO’s “best buys”. be overcome by any individual or entity acting alone. • The financial services sector – including impact investors and • Collective impact approaches and innovative partnerships insurance companies – can help governments to mobilize are essential to develop sustainable solutions. funding and private sector engagement on NCDs. This is critical in view of the US$ 2.5 trillion annual funding gap • Alignment with national strategies and the interests of that must be closed to achieve the SDG agenda. governments and decision-makers is essential to the success of country-level interventions.
• Conflicts of interest of industries that manufacture or trade in harmful products need to be recognized and managed.
58 | WHO – Copenhagen Report 59 60 | WHO – Copenhagen Report Annexes
04 ANNEX 1. PLENARY SPEECHES AND PRESENTATIONS
Opening ceremony Plenary 2 Development cooperation for NCDs: aligning Welcome speech by Martin Bille Hermann Secretary of State for Development Policy, Denmark and leveraging domestic and external resources to achieve SDG target 3.4 Opening address by H.R.H. Crown Princess Mary of Denmark
Opening address by Ulla Tørnæs Presentation by Téa Collins Minister of Development Cooperation, Denmark Adviser, Global Coordination Mechanism on NCD Prevention Opening address by Svetlana Akselrod and Control, WHO Assistant Director-General, Noncommunicable Diseases Presentation by Erika Placella and Mental Health, WHO Health Adviser, Swiss Agency for Development Opening address by Bente Mikkelsen and Cooperation Bente Mikkelsen, Director a.i., Division of Noncommunicable Presentation by Olayemi Cardoso Diseases and Promoting Health through the Life-course, Chairman of the Board of Directors, Citibank Nigeria WHO Regional Office for Europe Video message by Tim Evans Opening address by Dina Tadros Senior Director, Health, Nutrition and Population, World Bank Youth Representative (transcription pdf)
Plenary 1 Parallel session 2.1 Setting the stage: the role of partnerships Mobilizing resources for a joint United Nations and innovative financing to accelerate national system response to NCDs: the role of development NCD responses cooperation
Keynote presentation by Rifat Atun Presentations: Professor of Global Health Systems, T.H. Chan School of Public Health, Harvard University, Boston, MA, United States Nicholas Banatvala - Bollyky Presentation by Agnes Soucat WHO Parallel session 2.2 Presentation by Francine H.K. Ouedraogo Douamba Mobilizing domestic resources for NCDs: Ministry of Health, Burkina Faso learning from country experiences Presentation by Waleed Almanea Ministry of Health, Bahrain Carlos Lula - A brief story about the cancer fund experience Agnes Soucat - Sustainable financing for NCDs (setting the scene)
Parallel session 2.3 How to harness the power of the private sector to implement national NCD responses
Kaushik Ramiaya - Tanzania Diabetes Association Stephane Besançon - Diabetes care in Mali Andrea Atzori - Doctors with Africa
Note: This section includes speeches and PowerPoint presentations only. The valuable contributions of other panellists are reflected throughout the Global Dialogue report.
62 | WHO – Copenhagen Report ANNEX 1. PLENARY SPEECHES AND PRESENTATIONS
Parallel session 2.4 Partnership forum 2 Measuring resource flows into NCDs: NCDs and mental health in emergencies: current trends and projections beyond current financing
Presentations: Presentations:
Hafeez Ladha - Financing Alliance for Health Slim Slama - NCD Emergency Kit (version with video) Brenda Killen - New NCD dactracking codes Chisholm - NCD emergencies Intro Slim Slama - NCD Emergency Kit (light version)
Plenary session 3 Documents: Exploring synergies between financing The Development of a non-communicable diseases emergency national NCD responses and broader health health kit - EMHJ systems strengthening efforts for universal WHO sending NCDs medicines and materials kits to health coverage humanitarian crises (video, mp4)
Presentations: Rachel Nugent, RTI International Partnership forum 3 A vital investment: scaling up health workforce Parallel session 3.3 for NCDs
Building the investment case for Presentations: NCD prevention and control Isabel Jacinto - Answers to PF3 key questions
Presentations: Patrick Kupelian - Answers to PF3 key questions Isabel Jacinto - The role of pharmacists Stineke Oenema - Nutrition Decade IFMSA - Answers to PF3 key questions Robert Tripp - Conference of the Parties Francesca Celletti - Presentation Douglas Webb - NCDs Investment Cases Andreas Rudkjobing - Answers to PF3 key questions
Parallel session 3.4 Documents: Cost-effective and feasible solutions: A New Pharmacy Model_CESOP WHO “best buys”
Presentations:
Thaksaphon Thamarangsi - Investment for “Best Buys”
63 ANNEX 1. PLENARY SPEECHES AND PRESENTATIONS
Plenary 5 Multistakeholder and multisectoral action: a means to unlock financing for NCDs
Video message by Sania Nishtar Co-chair, WHO Independent High-level Commission on NCDs Keynote speech by Grete Faremo Undersecretary General, UNOPS (delivered by Nikolaj Gilbert) Keynote speech by Kristian Jensen Minister of Finance, Denmark Summary presentation by Guy Fones WHO Presentation by Bagher Larijani Ministry of Health and Medical Education, Islamic Republic of Iran Presentation by James Love Knowledge Ecology International Presentation by Mohammed Hamad Al Thani Ministry of Public Health, Qatar
Call to action and closure of the meeting
Closing address by Bente Mikkelsen WHO Closing address by Martin Bille Hermann Secretary of State for Development Policy, Denmark
Presentations:
Youth Innovation Lab - Health coins
Documents:
Solutions proposed by the Youth Innovation Lab talents
Note: This section includes speeches and PowerPoint presentations only. The valuable contributions of other panellists are reflected throughout the Global Dialogue report.
64 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
• List of participants
• Steering Committee
• Programme Committee
• Advisory Committee
• Conference Secretariat
List of participants Royalty
Denmark Her Royal Highness Crown Princess Mary Elizabeth of Denmark
Jordan Her Royal Highness Princess Dina Mired of Jordan President-Elect, Union for International Cancer Control (UICC)
Member States
Algeria Docteur Youcef Tarfani Directeur des maladies non transmissibles Ministère de la Santé, de la population et de la réforme hospitalière
Monsieur Abd El Hakim Belaid Directeur des Finances et des Moyens Ministère de la Santé, de la population et de la réforme hospitalière
Argentina Dr. Adolfo Rubinstein Ministro de Salud Ministerio de Salud
Dra. Vilma Irazola Directora Departamento de Investigación en Enfermedades Cronicas Centro de Excelencia en Salud Cardiovascular para América del Sur (CESCAS) Instituto de Efectividad Clinica y Sanitaria (IECS)
65 ANNEX 2. PARTICIPANTS AND LISTINGS
Bahrain Dr Waleed Khalifa Almanea Undersecretary Ministry of Health
Mr Mohamed Ahmed Alatawi Director of Finance Resource Directorate Ministry of Health
Benin Docteur Lucien Toko Directeur de Cabinet Ministère de la Santé
Monsieur Jean Toboula Contrôleur Budgétaire Conseiller Technique au Budget Ministère de l’Economie et des Finances
Brazil Dr Maria Angélica Borges dos Santos Physician and Researcher National School of Public Health, Oswaldo Cruz Foundation (ENSP/FIOCRUZ) Ministry of Health
Dr Carlos Eduardo De Oliveira Lula Secretary of Health of State of Maranhão Ministry of Health
Burkina Faso Docteur Francine H.K. Ouedraogo Douamba Secrétaire Général Ministère de la Santé
Docteur Estelle Edith Dembele Dabire Directrice de la Coordination des Projets et Programmes Ministère de la Santé
Cabo Verde Dr Maria Serafina Rocha Alves Tavares Directrice Générale de la Planification, Budget et Gestion Ministère de la Santé et de la Sécurité Sociale
Cameroon Docteur Hamadou Bâ Chef de la Division de la Coopération (DCOOP) Ministère de la Santé Publique
66 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Cameroon Monsieur François Cyril Effila Ndzemena Sectoriel MINSANTE Direction Générale du budget/Division de la préparation du Budget Ministère des Finances
Canada Dr Rachel Rodin Senior Medical Adviser Health Promotion and Chronic Disease Prevention Branch Public Health Agency
Ms Madiha Ahmed Senior Program Specialist International Development Research Centre
Central African Republic Monsieur Jean Vincent Mbenda Administrateur Civil Chef de Service des Etudes, de la Planification et de Gestion des Projet par interim Ministère de la Santé et de la Population
Chad Monsieur Ahmadou Djaouro Directeur de l’élaboration et du suivi budgétaire Ministère de la Santé Publique
Cuba Dr Marcy Calderón Martinez Head of Non-Communicable Diseases Department Ministry of Public Health
Czech Republic Mr Tomas Troch Officer, Department of Health Insurance Supervision Ministry of Health
Ms Eva Gajdosova Officer, Unit of Health and Public Health Insurance Ministry of Finance of the Czech Republic
Denmark Mr Kristian Jensen Minister for Finance Ministry of Finance
Ms Ulla Tørnæs Minister for Development Cooperation Ministry of Foreign Affairs
67 ANNEX 2. PARTICIPANTS AND LISTINGS
Denmark Mr Martin Bille Hermann State Secretary for Development Policy Ministry of Foreign Affairs
Ms Birgitte Mossing Bronden Chief Adviser and Team Leader Ministry of Foreign Affairs
Mr Jakob Skaarup Nielsen Chief Adviser Ministry of Foreign Affairs
Mrs Signe Albjerg Deputy Head of Department Ministry of Foreign Affairs
Ms Kirstine Thyge Nojgaard Ministry of Foreign Affairs
Dr Soeren Brostroem Director-General Danish Health Authority
Mrs Hanne Charlotte Findsen Head of Division Ministry of Health
Ms Simone Overby Sloth Head of Section Ministry of Health
Mr Jonas Vive Head of Section Danish Health Authority
Mr Mads Petersen Special Adviser Danish Health Authority
Ms Gitte Hundahl Minister Counsellor Permanent Mission of Denmark to the United Nations Office and other International Organizations at Geneva
68 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Estonia Ms Heli Laarmann Head of Public Health Department Ministry of Social Affairs
Mr Tanel Ross Adviser State Budget Department Ministry of Finance
Ethiopia Dr Feven Girma Assefa Resource Mobilization Directorate Ministry of Health
Fiji Mr Ami Prasad Acting Director Finance and Asset Management Ministry of Health and Medical Services
Finland Ms Leino Satu Special Adviser International Affairs Unit Ministry of Social Affairs and Health
France Monsieur Philippe Damie Conseiller Santé Mission permanente de la France auprès de l’Office des Nations Unies à Genève et des Institutions spécialisées ayant leur siège en Suisse
Gambia Ms Fatoumata Komma Non-Communicable Diseases Programme Officer Non-Communicable Diseases Unit Ministry of Health and Social Welfare
Ghana Dr Dennis Laryea Programme Manager Non-Communicable Diseases Control Ministry of Health
Mr Dennis Kwame Apreku Budget Officer Ministry of Finance
69 ANNEX 2. PARTICIPANTS AND LISTINGS
Guinea Professeur Naby Baldé Coordonnateur National du Programme de Lutte contre les Maladies non Transmisibles Ministère de la Santé
Guyana Mr Premchand Persaud Economist Ministry of Public Health
Haiti Docteur Yves Gaston Deslouches Membre du Cabinet de la Ministre Ministère de la Santé Publique et de la Population
Dr Tamara Georges Decastro Membre Cabinet Ministre Ministère de la Santé Publique et de la Population
Dr Joceline Pierre Louis Director of Health Promotion and Responsible of NCD Ministère de la Santé Publique et de la Population
Indonesia Mr Purwanto Director of Budget of Human and Culture Development Directorate General of Budget Ministry of Finance
Dr Nasruddin Djoko Surjono Deputy Director for Customs and Excise Policy Centre of State Revenue Policy Government of Indonesia
Iran (Islamic Republic of) Dr Bagher Larijani Deputy for Education and Vice President of Non-Communicable Diseases Ministry of Health and Medical Education
Dr Afshin Ostovar Director of Non-Communicable Diseases Ministry of Health and Medical Education
70 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Italy Dr Daniela Galeone Senior Medical Officer Ministry of Health
Dr Pasqualino Procacci Head of Human Development Office Italian Agency For Cooperation
Jamaica Ms Dian Black Acting Deputy Financial Secretary Economic Management Division Ministry of Finance and the Public Service
Dr Tamu Davidson Director NCDs and Injuries Prevention Ministry of Health
Jordan Dr Majed Masoud Asad Director of Non-Communicable Diseases Ministry of Health
Kenya Ms Dorcas Jepsongol Kiptui Head, Tobacco Control Unit Ministry of Health
Dr Hellen Kabiru Counsellor-Health Permanent Mission of the Republic of Kenya to the United Nations Office at Geneva and other Specialized Institutions in Switzerland
Luxembourg Dr Guillaume Campagné Physician Division of Preventive Medicine of the Health Directorate Ministry of Health
Malawi Dr Jones Kaponda Masiye Head of Non-Communicable Diseases and Mental Health Ministry of Health
71 ANNEX 2. PARTICIPANTS AND LISTINGS
Mali Docteur Cheickna Tounkara Chargé des Maladies Non Transmissibles Direction Nationale de la Santé
Mauritania Docteur Mohamed Laghdaf Sidi Directeur de la lutte contre les Maladies Non Transmissibles Ministère de la Santé
Mozambique Dr Juvenaldo Amós Head of Non-Communicable Diseases Department Ministry of Health
Myanmar Dr Ye Phyo Assistant Director, Non-Communicable Diseases Department of Public Health
Nepal Professor Dr Shrikrishna Giri Division Chief Policy, Planning and International Cooperation Division (PPICD) Ministry of Health and Population
Netherlands Dr Pieter de Coninck Senior Adviser Ministry of Health, Welfare and Sport
Niger Monsieur Mohamed Abdoulaye Directeur Général Adjoint du Budget Ministère des Finances
Nigeria Dr Nnenna Ezeigwe Director/National Coordinator NCDs Federal Ministry of Health
Mr Oluremi Adeola Onabajo Assistant Director Federal Ministry of Finance
72 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Norway Dr Astrid Nylenna MD/Project Manager Norwegian Directorate of Health
Mr Bengt Skotheim Project Manager Norwegian Directorate of Health
Mr Kjetil Bordvik Senior Adviser The Norwegian Agency for Development Cooperation (Norad)
Portugal Professor Fernando Araújo Secretary of State Assistant and of Health Ministry of Health
Dr Francisco Goiana da Silva Deputy Secretary of State Ministry of Health
Qatar Dr Mohammed Al-Thani Director of Public Health Ministry of Public Health
Russian Federation Dr Eduard Salakhov Deputy Director Department of International Cooperation and Public Affairs Ministry of Health
Dr Marina Popovich Head of the Integrated Prevention Programs Department Federal Research Center of Preventive Medicine Ministry of Health
Rwanda Dr Gilles François Ndayisaba Division Manager for Non-Communicable Diseases Ministry of Health
Sao Tome and Principe Dr. Lindley Rodrigues Monteiro de Jesus Assessor do Ministro Gabinete do Ministro das Finanças, Comércio e Economia Azul em S. Tomé
73 ANNEX 2. PARTICIPANTS AND LISTINGS
Saudi Arabia Dr Shaker Alomary General Director General Directorate of Health Program and Chronic Diseases Ministry of Health
Slovakia Ms Martina Veresova Director, Department of Public Expenditure and Economy Management Section Finance Ministry of Health
Mr Tomas Kudela Director, Department of Public Health Office of the State Secretary Ministry of Health
Spain Sra. Maria Victoria de Cea Martin Jefa de area de gestion y evaluacion de prestaciones sanitarias Ministerio de Hacienda y Función Pública (MUFACE)
Dr Isabel Saiz Martinez-Acitores Program Coordinator Subdirectorate of Quality and Innovation General Directorate of Public Health, Quality and Innovation Ministry of Health, Social Services and Equality
Sri Lanka Ms Ajitha Batagoda Director Ministry of Finance and Mass Media
Sweden Mr Mikael Lindman Deputy Director Ministry of Health and Social Affairs
Mr Johan Westlund Legal Adviser Ministry of Finance
74 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Switzerland Ms Enrichetta Placella Health Adviser Eastern Europe and Central Asia Federal Department of Foreign Affairs (FDFA) Swiss Agency for Development and Cooperation (SDC)
Ms Carla Koch Adviser Global Health Governance Federal Department of Foreign Affairs (FDFA) Swiss Agency for Development and Cooperation (SDC)
Dr Anna Julia Berger Scientific Adviser Federal Office of Public Health (FOPH) Section Prevention in Health Care (PGV)
Ms Rhena Forrer Adviser Federal Department of Home Affairs (FDHA) Swiss Federal Office of Public Health
Timor-Leste Dr Federico Bosco Alves dos Santos Head of Department for NCD Ministry of Health
Uganda Dr Gerald Mutungi Programme Manager Non-Communicable Diseases (NCDs) Prevention and Control Programme Ministry of Health
United Republic of Tanzania Ms Sarah Maongezi Senior Officer and Acting Assistant Director of Non-Communicable Diseases Section Ministry of Health, Community Development, Gender, Elderly and Children
75 ANNEX 2. PARTICIPANTS AND LISTINGS
United States of America Mr Garrett Grigsby Director Office of Global Affairs U.S. Department of Health and Human Services
Ms Jenifer Healy Chief of Staff Office of Global Affairs U.S. Department of Health and Human Services
Mr Kyle Zebley Senior Adviser Office of Global Affairs U.S. Department of Health and Human Services
Ms Maya Levine Senior Global Health Officer Office of Global Affairs U.S. Department of Health and Human Services
Uruguay Dra. Raquel Rosa Directora General de la Salud Ministerio de Salud Pública
Sr. Pablo Ferreri SubSecretario Ministerio de Economía y Finanzas
Ms Cristina Gonzalez Minister Counsellor Permanent Mission of Uruguay to the United Nations Office and other International Organizations at Geneva
Zambia Dr Francisco Simenda Mental Health Coodinator Ministry of Health
Zimbabwe Dr Justice Mudavanhu Deputy Director, Non-Communicable Diseases Ministry of Health and Child Care
Mr Nobert Machinjike Principal Economist Ministry of Finance and International Trade
76 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
United Nations and related organizations
Ms Carlotta Barcaro Corporate Research Manager United Nations Children’s Fund (UNICEF)
Mr Mukul Bhola Head of Geneva Liaison Office, Partnerships Group United Nations Office for Project Services (UNOPS)
Ms Grete Faremo Under-Secretary-General and Executive Director United Nations Office for Project Services (UNOPS)
Mr Nikolaj Gilbert Partnerships Director United Nations Office for Project Services (UNOPS)
Mr Moin Karim Regional Director for Europe and Central Asia United Nations Office for Project Services (UNOPS)
Dr Akihiro Seita Director of Health United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA)
Dr Douglas Webb Team Leader, Health, Gender and Environment United Nations Development Programme (UNDP)
Dr Eduardo Zubizarreta Section Head International Atomic Energy Agency (IAEA)
77 ANNEX 2. PARTICIPANTS AND LISTINGS
Intergovernmental organizations
Ms Brenda Killen Corporate Research Manager Deputy Director Organisation for Economic Co-operation and Development (OECD)
Ms Birgit Morlion Programme Officer, eHealth, Well-being and Ageing European Commission
Mr Pierre Roca International Cooperation Officer, Health Policy Directorate General for International Cooperation and Development (DEVCO) European Commission
Other participants
Dr Kamran Abbasi Executive Editor British Medical Journal (BMJ)
Ms Mariam Abdoh Programs Development and Advocacy Manager Royal Health Awareness Society
Dr Cary Adams Chief Executive Officer Union for International Cancer Control (UICC)
Dr Fiona Adshead Deputy Chief Executive NCD Alliance
Mr A R M Mehrab Ali Youth Innovation Lab
78 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Dr Amal Al Muraikhi Health Sector Programs Manager Fund for Development
Mr Andrea Atzori Head of International Relations Doctors with Africa Cuamm
Mr Oystein Bakke Secretary Global Alcohol Policy Alliance (GAPA)
Mr Thirukumaran Geneva Representative Balasubramaniam Knowledge Ecology International
Dr Eduardo Banzon Principal Health Specialist Asian Development Bank
Ms Josianne Galea Baron Youth Innovation Lab
Dr Simon Barquera Director, Centre for Nutrition and Health National Public Health Institute (INSP), Mexico
Mr Martin Bernhardt Vice President Public Affairs and Global Health Sanofi, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Ms Florence Berteletti Director of Advocacy World Heart Federation
Ms Benita Bertram Director, Strategy and Operations World Diabetes Foundation
Mr Stephane Besançon Chief Executive Officer NGO Santé Diabète
Ms Jill Birnbaum Vice President, Global Advocacy American Heart Association
79 ANNEX 2. PARTICIPANTS AND LISTINGS
Mr Thomas Bollyky Senior Fellow Council on Foreign Relations
Mr Mikael Bonde Nielsen Co-chair Representative International Food & Beverage Alliance
Mr Nicolai Boserup Senior Vice President Investment Fund for Developing Countries (IFU)
Dr Gene Bukhman Director Program in Global NCDs and Social Change
Professor Ib Bygbjerg Youth Innovation Lab
Ms Vanessa Candeias Head of Global Health and Healthcare World Economic Forum (WEF)
Mr Olayemi Cardoso Chairman Citibank Nigeria
Mr Bruno Carrattini Moraes Youth Innovation Lab
Dr Francesca Celletti Vice President Strategy Corvus Health
Mr Dirk Lund Christensen Youth Innnovation Lab
Mr Thomas Cueni Director-General International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Professor Abdallah Daar Board Member World Diabetes Foundation
80 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Ms Katie Dain Chief Executive Officer NCD Alliance
Mrs Tamari Dakhundaridze Youth Innovation Lab
Dr Damiano de Felice Director of Strategy Access to Medicine Foundation
Mr Diogo De Sousa Neves Youth Innovation Lab
Ms Sanne de Wit Liaison Officer for Public Health Issues International Federation of Medical Students’ Associations
Ms Masha DeVoe Senior Associate Women Deliver
Professor Oxana Domenti Professor School of Public Health Management of Chisinau
Mr Franck Droin President KAISSA for AEIP
Ms Sabine Dupont Senior Advocacy Manager International Diabetes Federation
Mr Luis Manuel Youth Innovation Lab Encarnacion Cruz
Mrs Charlotte Ersboll Senior Adviser Christoffersen UN Global Compact
Ms Amy Eussen Chair Elect NCD Child
81 ANNEX 2. PARTICIPANTS AND LISTINGS
Dr Mychelle Farmer Chair NCD Child
Dr Andrea Feigl Health Economist Organisation for Economic Co-operation and Development (OECD)
Mr Leif Fenger Jensen Managing Director World Diabetes Foundation
Mr Jack Fisher Executive Director NCDFREE
Ms Corinne Fitzgerald Researcher Swiss Re Institute Company
Ms Sanne Frost Helt Co-chair WHO GCM Working Group 3.1
Ms Amira Ghouaibi Community Lead World Economic Forum
Ms Celina Gorre Executive Director Global Alliance for Chronic Diseases
Ms Mia Grupper Executive Director World Stroke Organization
Sarah Harrison Technical Adviser International Federation of Red Cross and Red Crescent Societies (IFRC) Reference Centre for Psychosocial Support
Mrs Marie Hauerslev Youth Innovation Lab
Mrs Anna Holm Loekke Youth Innovation Lab
82 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Ms Laura Hucks Regional Office for the Americas (AMRO) NCD Alliance
Mr Stefan Islandi Director of Development NCD Alliance Denmark
Ms Amy Israel Director, Global Health and Policy Eli Lilly, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Ms Isabel Jacinto Pharmacist National Association of Pharmacies
Professor Stephen Jan Professor of Health Economics George Institute for Global Health
Ms Jordan Jarvis Director of Programs Young Professionals Chronic Disease Network
Mr Thusitha Darshana Youth Innovation Lab Kahaduwa Kahaduwage
Ms Priya Kanayson Senior Advocacy Officer NCD Alliance
Dr Mukesh Kapila Chief Executive Defeat-NCD Partnership
Dr Anil Kapur Chairman of Board World Diabetes Foundation
Mr David Karorero Youth Innovation Lab
Dr Ishu Kataria Public Health Researcher Young Professionals Chronic Disease Network
83 ANNEX 2. PARTICIPANTS AND LISTINGS
Mr Ahmed Ibrahim Mohamed Youth Innovation Lab Elsayed Khedr
Professor Ilona Kickbusch Director Global Health Centre Graduate Institute
Mr Tryggve Kielland Special Adviser Norwegian Cancer Society
Professor Jonathan Klein Immediate Past-Chair, NCD Child NCD Child/International Pediatric Association
Mr Grega Kumer Head of Director-General Office International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Professor Patrick Kupelian Vice President Medical Affairs
Mr Hafeez Ladha Director, Innovative Finance Financing Alliance for Health
Mr Julien Lafleur Deputy Secretary General International Food & Beverage Alliance
Mr Bent Lautrup-Nielsen Senior Adviser World Diabetes Foundation
Ms Maria Lentz Nielsen Youth Innovation Lab
Ms Erica Levine Program Manager Arnhold Institute for Global Health at Mount Sinai School of Medicine
Mrs Helena Levison Youth Innovation Lab
84 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Ms Erin Little Executive Director Young Professionals Chronic Disease Network
Mr Chenchao Liu Youth Innovation Lab
Mr James Love Director Knowledge Ecology International
Mr Niels Lund Vice President, Health Advocacy Novo Nordisk, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Dr Harris Lygidakis Honorary Secretary (WONCA Europe) World Organization of Family Doctors (WONCA)
Ms Camille Mary Administrative-Financial Manager NGO Sante Diabete
Ms Helen McGuire Global Program Leader PATH
Ms Helen Medina Co-chair Representative International Food & Beverage Alliance
Dr Rachel Melsom Director, UK & Europe Tobacco Free Portfolios
Dr Domenico Messina Representative at WHO International Association of Lions Clubs
Mr George Leonard Msengi Youth Innovation Lab
Mr Dorje Mundle Director Business for Social Responsibility (BSR)
85 ANNEX 2. PARTICIPANTS AND LISTINGS
Dr Mellany Murgor Africa Director Youth Innovation Lab
Mrs Tanne Noergaard Youth Innovation Lab
Professor Bo Norrving Professor World Stroke Organization
Dr Rachel Nugent Vice President, Global Non-Communicable Diseases RTI International
Dr Harald Nusser Head, Social Business Novartis, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Ms Morten Nyegaard Youth Innovation Lab
Ms Hanin Odeh Director-General Royal Health Awareness Society
Mr Mads Odgaard Youth Innovation Lab
Dr Davide Olchini Head of Prevention and Health Unit Humanity & Inclusion (Handicap International)
Ms Charlotte O’Leary Policy Coordinator NCDFREE
Ms Isabella Frederikke Øllgaard Department of Sociology University of Copenhagen
Ms Maia Olsen Program Manager, NCD Synergies Partners In Health
86 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Mr James Pfitzer Director Access Accelerated
Mr Andersson Pierre Policy Adviser IOGT International
Ms Johanna Ralston Chief Executive Officer World Obesity Federation
Dr Kaushik Ramaiya General Secretary Tanzania Diabetes Association
Ms Soraya Ramoul Director, Global Access to Care Novo Nordisk, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Mr Dinuke Ranasinghe Board Member Defeat-NCD Partnership
Mr Thalagaha Gedara Sankha Youth Innovation Lab Dashanana Randenikumara
Ms Jessica Renzella Strategic Development Coordinator NCDFREE
Dr Rodrigo Rodriguez Fernandez Global Medical Director International SOS
Dr Andreas Rudkjoebing World Medical Association Council World Medical Association (WMA)
Mr Mike Rulis Vice-Chairman of Board World Diabetes Foundation
Dr Id Rusen Senior Adviser The Union
87 ANNEX 2. PARTICIPANTS AND LISTINGS
Ms Anne Lise Ryel Secretary General Norwegian Cancer Society
Ms Rhea Saksena Global Policy Coordinator NCDFREE
Dr Jennifer Sargent Senior Editor The Lancet
Professor Franco Sassi Professor of International Health Policy and Economics Imperial College London
Ms Ann Marie Sevcsik Program Director, Health and Humanitarian Response UBS Optimus Foundation
Dr George Shakarishvili Senior Adviser, Health Systems The Global Fund to Fight HIV/AIDS, TB and Malaria
Ms Laura Solia Shellaby City Health Financing Lead Union for International Cancer Control (UICC)
Ms Kristina Sperkova President IOGT International
Dr Singh Sudhvir Policy Director EAT Foundation
Mr Stig Tackmann Youth Innovation Lab
Ms Dina Tadros Youth Innovation Lab
Dr Julia Tainijoki Seyer Medical Adviser World Medical Association
88 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Ms Rowena Tasker Advocacy Manager Union for International Cancer Control
Mr Mischa Terzyk Policy & Advocacy Officer Framework Convention Alliance
Mr Francis Thompson Executive Director Framework Convention Alliance for Tobacco Control
Mrs Eva Thomsen Youth Innovation Lab
Mr Armstrong Ntiabang Tih Regional Coordinator WHO Regional Office for Africa
Mrs Julie Traerup Youth Innovation Lab
Mr Alan Trager President PPP Initiative Ltd
Ms Chinwendu Genevieve Youth Innovation Lab Ukachukwu
Mrs Hans Uldal Youth Innovation Lab
Mr Baptiste Vasey Fellow Mercator Fellowship on International Affairs
Mrs Mirjam Wajsberg Youth Innovation Lab
Mr Alastair White Policy & Advocacy Officer World Heart Federation
89 ANNEX 2. PARTICIPANTS AND LISTINGS
Dr Si Thu Win Tin NCD Team Leader Pacific Community (SPC)
Ms Yifan Zhu Youth Innovation Lab
WHO Secretariat
Dr Svetlana Akselrod Assistant Director-General of Noncommunicable Diseases and Mental Health
Dr Francesco Branca Director, Nutrition for Health and Development
Dr Anselm Joseph Mark Hennis Director, Noncommunicable Diseases and Mental Health
Dr Hans Henri Kluge Director, Health Systems and Public Health Regional Office for Europe
Dr Bente Mikkelsen Bente Mikkelsen, Director a.i., Division of Noncommunicable Diseases and Promoting Health through the Life-course Regional Office for Europe
Dr Agnes Soucat Director, Health Systems Governance and Financing
Dr Thaksaphon Thamarangsi Director, Noncommunicable Diseases & Environmental Health Regional Office for South-East Asia (SEARO)
Dr Guy Fones Acting Head, Secretariat of the WHO Global Coordination Mechanism on Noncommunicable Diseases
Mrs Marge Reinap Head of WHO Country Office, Estonia
90 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Dr Joao Joaquim Rodrigues Da Head, Integrated Prevention and Control of NCDs Silva Breda Regional Office for Europe (EURO)
Dr Katia De Pinho Campos Coordinator, Noncommunicable Diseases & Determinants of Health Regional Office for the Americas (AMRO)
Dr Jill Farrington Coordinator, Senior Technical Officer, Integrated Prevention and Control of Noncommunicable Diseases Regional Office for Europe (EURO)
Mr Jeremias Jr Paul Coordinator, Tobacco Control
Dr Nicholas Banatvala Manager, United Nations Interagency Task Force on the Prevention and Control of Noncommunicable Diseases
Ms Melanie Bertram Technical Officer, Economic Analysis and Evaluation
Dr Daniel Chisholm Programme Manager for Mental Health Regional Office for Europe
Mr David Clarke Team Leader, UHC and Health Systems Law
Dr Téa Collins Adviser, Secretariat of the WHO Global Coordination Mechanism on Noncommunicable Diseases
Ms Nicoletta De Lissandri Assistant to Director, Secretariat of the WHO Global Coordination Mechanism on Noncommunicable Diseases
Dr Gwenael Dhaene Health Systems Adviser, Health Systems Governance and Financing
Mrs Amelie Keller Intern Regional Office for Europe (EURO)
91 ANNEX 2. PARTICIPANTS AND LISTINGS
Mrs Tina Charlotte Kiaer Communications Officer, Noncommunicable Diseases and Promoting Health through the Life-Course Regional Office for Europe (EURO)
Dr Mary-Anne Land Technical Officer, Management of Noncommunicable Diseases, Disability, Violence & Injury Prevention
Ms Guangyuan Liu Team Leader WHO Framework Convention on Tobacco Control (FCTC)
Dr Lucero Diana Lopez Perez App Manager, Evidence and Programme Guidance
Dr Ricardo Xavier Martinez Statistician and Public Health Adviser, Evidence and Programme Guidance Martinez
Mrs Kristina Mauer Stender Programme Manager, Tobacco Control Regional Office for Europe (EURO)
Dr Filip Meheus Health Economist International Agency for Research on Cancer (IARC)
Ms Line Neerup Handlos Consultant Regional Office for Europe (EURO)
Ms Liuba Negru Communications Officer, Corporate Communication Regional Office for Europe (EURO)
Ms Angkana Santhiprechachit Administration and Finance Officer International Agency for Research on Cancer (IARC)
Dr Slim Slama Regional Adviser, Noncommunicable Diseases Prevention Regional Office for Eastern Mediterranean (EMRO)
Mr Ian Stein Senior Adviser, External Relations & Partnerships Regional Office for the Americas (AMRO)
92 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Mr Robert Tripp Senior Adviser WHO Framework Convention Tobacco Control (FCTC)
Dr Tatiana Vorovchenko Communications Officer, Office of the Assistant Director-General, Noncommunicable Diseases and Mental Health
Steering Committee
Bente Mikkelsen (Co-chair) WHO Regional Office for Europe
Birgitte Mossin Bronden Chief Adviser, Danish Ministry of Foreign Affairs (Co-chair)
Douglas Bettcher Prevention of NCDs Department (PND)
Francesco Branca Department of Nutrition for Health and Development (NHD)
Gitte Hundahl Danish Mission to Geneva
Etienne Krug Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention (NVI)
Shekhar Saxena Department of Mental Health and Substance Abuse (MSD)
Menno Van Hilten Assistant Director-General’s Office
93 ANNEX 2. PARTICIPANTS AND LISTINGS
Members of WHO Global Dialogue Programme Committee
Téa Collins (Chair, Global Global Coordination Mechanism on the Prevention and Control Dialogue Coordinator) of Noncommunicable Diseases (GCM/NCD)
Nick Banatvala United Nations Interagency Task Force on the Prevention and Control of NCDs (UNIATF)
Annie Chu Regional Office for the Western Pacific
Guy Fones Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases (GCM/NCD)
Paul Garwood Department of Communications
Sophie Genay-Diliautas Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases (GCM/NCD)
Marta Guglielmetti Prevention of NCDs Department (PND)
Anselm Hennis Pan American Health Organization
Alexey Kulikov United Nations Interagency Task Force on the Prevention and Control of NCDs (UNIATF)
Mary-Anne Land Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention (NVI)
Lina Mahy Department of Nutrition for Health and Development (NHD)
94 | WHO – Copenhagen Report ANNEX 2. PARTICIPANTS AND LISTINGS
Daniel Míc Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases (GCM/NCD)
Line Neerup Handlos Department of Food Safety and Zoonoses (FOS)
Marge Reinap WHO Regional Office for Europe
Dag Rekve Department of Mental Health and Substance Abuse (MSD)
Steven Shongwe Regional Office for Africa
Slim Slama Regional Office for the Eastern Mediterranean
Tatiana Vorovchenko Assistant Director-General’s Office
95 ANNEX 2. PARTICIPANTS AND LISTINGS
Advisory Committee
Katie Dain (Co-chair) NCD Alliance
Bent Lautrup-Nielsen (Co-chair) World Diabetes Foundation
Benita Bertram World Diabetes Foundation
Vanessa Candeias World Economic Forum
Priya Kanayson NCD Alliance
Grega Kumer International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
James Pfitzer International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
96 | WHO – Copenhagen Report
Conference Secretariat
Téa Collins
Corinne Desfarges
Guy Fones
Sophie Genay-Diliautas
Nicoletta de Lissandri
Daniel Míc
Line Neerup Handlos
Dina Tadros
Hannah Todd
Baptiste Vasey
97 ANNEX 3. IMAGE GALLERY
More than 300 participants from over 56 countries, including governments, United Nations agencies and non-State actors, came together on 9–11 April 2018 in Copenhagen, Denmark.
98 | WHO – Copenhagen Report ANNEX 3. IMAGE GALLERY
Participants convened to discuss how collective efforts and innovative approaches can accelerate the implementation of high-level political commitments for the achievement of the Sustainable Development Goals.
99 ANNEX 3. IMAGE GALLERY
Participants expressed that while traditional funding patterns and public-private partnerships are critical for mobilizing resources, innovative and alternative sources and partnership modalities for collaboration also need to be considered.
100 | WHO – Copenhagen Report ANNEX 3. IMAGE GALLERY
101 ANNEX 3. IMAGE GALLERY
The Government of Denmark announced its commitment to support the Defeat- NCD Partnership and set up an SDG fund to secure the implementation of the 2030 Agenda for Sustainable Development, focusing on the challenges that low- and middle- income countries face.
102 | WHO – Copenhagen Report ANNEX 3. IMAGE GALLERY
103 ANNEX 3. IMAGE GALLERY
The Global Dialogue provided an effective platform to launch the Lancet series on NCDs and economics.
104 | WHO – Copenhagen Report ANNEX 3. IMAGE GALLERY
105 ANNEX 3. IMAGE GALLERY
The Dialogue reiterated the fact that public resources are not sufficient to overcome the NCD challenge and incentives are needed for the private sector to support financing of national NCD responses.
106 | WHO – Copenhagen Report © World Health Organization 2019